Perfil (CV) del personal docente investigador

Artículos

• Grasa, Laura; Chueca, Eduardo; Arechavaleta, Samantha; García-González, María Asunción; Sáenz, María Ángeles; Valero, Alberto; Hördnler, Carlos; Lanas, Ángel; Piazuelo, Elena. Antitumor effects of lactate transport inhibition on esophageal adenocarcinoma cells. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY. 2023. DOI: 10.1007/s13105-022-00931-3
  
  
• Irún, Pilar; Carrera-Lasfuentes, Patricia; Sánchez-Luengo, Marta; Belio, Úrsula; Domper-Arnal, María José; Higuera, Gustavo A.; Hawkins, Malena; de la Rosa, Xavier; Lanas, Angel. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023. DOI: 10.3390/ijms242216143
  
  
• Hijos-Mallada, Gonzalo; Saura, Nuria; Lué, Alberto; Velamazan, Raúl; Nieto, Rocío; Navarro, Mercedes; Arechavaleta, Samantha; Chueca, Eduardo; Gomollon, Fernando; Lanas, Angel; Sostres, Carlos. A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer. CANCERS. 2023. DOI: 10.3390/cancers15030721
  
  
• García-Mateo, Sandra; Lanas, Angel. Editorial: Improving the gut microbiome: applications of fecal transplantation in disease. FRONTIERS IN MEDICINE. 2023. DOI: 10.3389/fmed.2023.1203448
  
  
• Lanas, Á.; Tacconelli, S.; Contursi, A.; Piazuelo, E.; Bruno, A.; Ronci, M.; Marcone, S.; Dovizio, M.; Sopeña, F.; Falcone, L.; Milillo, C.; Mucci, M.; Ballerini, P.; Patrignani, P. Biomarkers of response to low-dose aspirin in familial adenomatous polyposis patients. CANCERS. 2023. DOI: 10.3390/cancers15092457
  
  
• Hermoso-Durán, S.; Domper-Arnal, M. J.; Roncales, P.; Vega, S.; Sánchez-Gracia, Ó.; Ojeda, J. L.; Lanas, Á.; Velázquez-Campoy, A.; Abian, O. Bowel preparation for colonoscopy changes serum composition as detected by thermal liquid biopsy and fluorescence spectroscopy. CANCERS. 2023. DOI: 10.3390/cancers15071952
  
  
• Irún, Pilar; Gracia, Rafael; Piazuelo, Elena; Pardo, Julián; Morte, Elena; Paño, José Ramon; Boza, Julio; Carrera-Lasfuentes, Patricia; Higuera, Gustavo A.; Lanas, Ángel. Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study. SCIENTIFIC REPORTS (NATURE PUBLISHING GROUP). 2023. DOI: 10.1038/s41598-023-33682-2
  
  
• Borao Laguna, Cristina; Lanas, Ángel. Advances in the pharmacotherapeutic management of refractory peptic ulcers. EXPERT OPINION ON PHARMACOTHERAPY. 2023. DOI: 10.1080/14656566.2023.2199922
  
  
• Hijos-Mallada, Gonzalo; Alfaro, Enrique; Navarro, Mercedes; Cañamares, Pablo; Ariño, Inés; Charro, Mara; Bruno, Carlo; Solano, Marina; Pardillos, Ana; Jimeno, Cristina; Carrera-Lasfuentes, Patricia; Lanas, Angel; Domper-Arnal, Maria Jose. Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation. GASTROENTEROLOGIA Y HEPATOLOGIA. 2023. DOI: 10.1016/j.gastrohep.2023.01.007
  
  
• Alfaro, Enrique; Sostres, Carlos; Lanas, Angel. Diagnosis and treatment of helicobacter pylori infection in real practice—new role of primary care services in antibiotic resistance era. DIAGNOSTICS. 2023. DOI: 10.3390/diagnostics13111918
  
  
• Lanas, Ángel; Balaguer, Francesc; Sánchez-Luengo, Marta; Hijos-Mallada, Gonzalo; Hernández-Mesa, Goretti; Piñero, Melisa; Castillo, Joaquin; Ocaña, Teresa; Cubiella, Joaquín; Crespo, Anais; Iglesias, Águeda; Medeiros, Isabel; Cacho, Guillermo; Jover-Martínez, Rodrigo; Alustiza, Miren; Diaz-Tasende, José; Poves, Carmen; Macedo, Guilherme; Quintero, Enrique; Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023. DOI: 10.1002/ueg2.12446
  
  
• Bordin, Dmitry S.; Livzan, Maria A.; Gaus, Olga V.; Mozgovoi, Sergei I.; Lanas, Angel. Drug-associated gastropathy: diagnostic criteria. DIAGNOSTICS. 2023. DOI: 10.3390/diagnostics13132220
  
  
• Ariño-Pérez, I.; Martínez-Domínguez, S. J.; Alfaro almajano, E.; Carrera-Lasfuentes, P.; Lanas, Á. Mistakes in the diagnosis and treatment of Helicobacter pylori infection in daily clinical practice. HELICOBACTER. 2023. DOI: 10.1111/hel.12957
  
  
• Azagra, Pablo; Sostres, Carlos; Ferrández, Ángel; Riazuelo, Luis; Tomasini, Clara; Barbed, O. León; Morlana, Javier; Recasens, David; Batlle Martínez, Víctor; Gómez-Rodríguez, Juan J.; Elvira, Richard; López, Julia; Oriol, Cristina; Civera, Javier; Tardós, Juan D.; Murillo, Ana C.; Lanas, Angel; Montiel, José M. M. Endomapper dataset of complete calibrated endoscopy procedures. SCIENTIFIC DATA. 2023. DOI: 10.1038/s41597-023-02564-7
  
  
• Lanas, Angel; Werz, Oliver; Mikhail, Engy. Comparison of gastrointestinal adverse events between fast release tablets and regular acetylsalicylic acid (aspirin) galenics after short-term use: a meta-analysis of randomized clinical trials. INFLAMMOPHARMACOLOGY. 2023. DOI: 10.1007/s10787-023-01264-3
  
  
• Lanas, Angel; Andrews, Jane M; Lau, James; Toruner, Murat; Bromley, Susan E; Gralnek, Ian M. Management of iron-deficiency anemia following acute gastrointestinal hemorrhage: A narrative analysis and review. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (AUSTRALIA). 2023. DOI: 10.1111/jgh.16033
  
  
• Domper Arnal, María José; Hijos-Mallada, Gonzalo; Lanas, Ángel. Gastrointestinal and cardiovascular adverse events associated with NSAIDs. EXPERT OPINION ON DRUG SAFETY. 2022. DOI: 10.1080/14740338.2021.1965988
  
  
• Martínez Domínguez, S. J.; Lanas, Á.; Domper Arnal, M. J. Esófago de Barrett, hacia la mejora de la práctica clínica. MEDICINA CLINICA. 2022. DOI: 10.1016/j.medcli.2022.02.012
  
  
• Solanas, Estela; Sanchez-Fuentes, Nieves; Serrablo, Alejandro; Lue, Alberto; Lorente, Sara; Cortés, Luis; Lanas, Angel; Baptista, Pedro M.; Serrano, M. Trinidad. How Donor and Surgical Factors Affect the Viability and Functionality of Human Hepatocytes Isolated From Liver Resections. FRONTIERS IN MEDICINE. 2022. DOI: 10.3389/fmed.2022.875147
  
  
• Ariño Pérez, I.; Martínez Domínguez, S. J.; Alfaro Almajano, E.; Carrera Lasfuentes, P.; Lanas, Á. Management of Helicobacter Pylori infection and effectiveness rates in daily clinical practice in Spain: 2010–2019. ANTIBIOTICS. 2022. DOI: 10.3390/antibiotics11050698
  
  
• González, Andrés; Casado, Javier; Gündüz, Miyase Gözde; Santos, Brisa; Velázquez-Campoy, Adrián; Sarasa-Buisan, Cristina; Fillat, María F.; Montes, Milagrosa; Piazuelo, Elena; Lanas, Ángel. 1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori. FRONTIERS IN MICROBIOLOGY. 2022. DOI: 10.3389/fmicb.2022.874709
  
  
• Nyssen, O. P. ; Vaira, D. ; Pérez Aísa, Á. ; Rodrigo, L. ; Castro-Fernandez, M. ; Jonaitis, L. ; Tepes, B. ; Vologzhanina, L. ; Caldas, M. ; Lanas, A. ; Lucendo, A. J. ; Bujanda, L. ; Ortuño, J. ; Barrio, J. ; Huguet, J. M. ; Voynovan, I. ; Pérez Lasala, J. ; Sarsenbaeva, A. S.; Fernández-Salazar, L. ; Molina-Infante, J. ; Brglez Jurecic, N. ; Areia, M. ; Gasbarrini, A. ; Kupcinskas, J. ; Bordin, D. ; Marcos-Pinto, R. ; Lerang, F. ; Leja, M. ; Buzas, G. M. ; Niv, Y. ; Rokkas, T. ; Phull, P. ; Smith, S. ; Shvets, O. ; Venerito, M. ; Milivojevic, V. ; Simsek, I. ; Lamy, V. ; Bytzer, P. ; Boyanova, L. ; Kunovský, L. ; Beglinger, C. ; Doulberis, M. ; Marlicz, W. ; Goldis, A. ; Tonkic, A. ; Capelle, L. ; Puig, I. ; Megraud, F. ; O’morain, C. ; Gisbert, J. P. ; Fiorinni, G. ; Saracino, I. M. ; Pabon Carrasco, M. ; Keco Huerga, A. ; Alfaro Almajano, E. ; Martinez Dominguez, S. J. ; Alonso Galan, H. ; Velayos, B. ; Dueñas Sadornil, C. ; Botargues Bote, J. M. ; González-Cordero, P. ; Gómez Rodriguez, B. J. ; Pellicano, R. ; Nuñez, Ó. ; Franceschi, F. ; Alekseenko, S. ; Perona, M. ; Abdulkhakov, R. ; Domínguez-Cajal, M. ; Almela Notari, P. ; Gómez Camarero, J. ; Jiménez Moreno, M. ; Algaba, A. ; Bermejo, F. ; Tejedor Tejada, J. ; Susanibar, E. O. ; Boltin, D. ; Georgopoulos, S. ; O’morain, C. ; Qasim, A. ; Beales, I. ; Bakulina, N. ; Fadeenko, G. ; Malfertheiner, P. ; Rosania, R. ; Ilchishina, T. ; Bogomolov, P. ; Bakulin, I. ; Zaytsev, O. ; Gravina, A. G. ; Romano, M. ; Di Leo, A. ; Losurdo, G. ; Grigorieva, L. ; Delgado Guillena, P. ; Marusic, M. ; Jurcic, D. ; Dekhnich, N. N. ; Iyo, E. ; Peña Negro, L.C. de la ; Baryshnikova, N. ; Bakanova, N. ; Simsek, H. ; Simsek, C. ; Gridnyev, O. ; Fernández-Bermejo, M. ; Angueira, T. ; Ruiz-Zorrilla López, R. ; Gómez, B. ; Kovacheva-Slavova, M. ; Lahat, A. ; Alcedo, J. ; Campillo, A. ; Belousova, L. N. ; Pajares Villarroya, R. ; Ljubicic, N. ; Nikolic, M. ; González-Santiago, J. M. ; Burgos Santamaría, D. ; Pakhomova, A. ; Sekulic-Spasic, I. ; Ghisa, M. ; Farinati, F. ; Sagdati, S. I. ; Panic, N. ; Heluwaert, F. ; Amorena, E. ; Moreira, L. ; Fernández Esparrach, G. ; Plotnikova, E. Y. ; Kukla, M. ; Kamburov, V. ; Lamuela Calvo, L. J. ; Rankovic, I. ; Cuadrado Lavín, A. ; Arguedas Lázaro, Y. ; González Carrera Agnieszka Dobrowolska, V. ; Eder, P. ; Kononova, A. ; European Registry On Helicobacter Pylori Management Hp-Eureg Investigators. Empirical Second-Line Therapy in 5000 patients of the european registry on Helicobacter pylori management (Hp-EuReg). CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2022. DOI: 10.1016/j.cgh.2021.12.025
  
  
• Alfaro, Enrique; Martínez-Domínguez, Samuel J.; Laredo, Viviana; Lanas, Ángel; Sostres, Carlos. Evaluation of different strategies to improve the management of Helicobacter Pylori infection at the primary care level: training sessions increase prescription appropriateness of treatment regimens. ANTIBIOTICS. 2022. DOI: 10.3390/antibiotics11121746
  
  
• Hernandez-Ainsa, M.; Velamazan, R.; Lanas, A.; Carrera-Lasfuentes, P.; Piazuelo, E. Blood-cell-based inflammatory markers as a useful tool for early diagnosis in colorectal cancer. FRONTIERS IN MEDICINE. 2022. DOI: 10.3389/fmed.2022.843074
  
  
• Lanas, Angel; Santilli, Francesca. Aspirin and Helicobacter pylori interaction. THE LANCET. 2022. DOI: 10.1016/S0140-6736(22)02000-1
  
  
• Lanas, Angel; García-Rayado, Guillermo. Insights in gastroenterology: 2021. FRONTIERS IN MEDICINE. 2022. DOI: 10.3389/fmed.2022.1008157
  
  
• Casado, Javier; Lanas, Ángel; González, Andrés. Two-component regulatory systems in Helicobacter pylori and Campylobacter jejuni: attractive targets for novel antibacterial drugs. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2022. DOI: 10.3389/fcimb.2022.977944
  
  
• Montoro, Miguel; Cucala, Mercedes; Lanas, Ángel; Villanueva, Cándido; Hervás, Antonio José; Alcedo, Javier; Gisbert, Javier P.; Aisa, Ángeles P.; Bujanda, Luis; Calvet, Xavier; Mearin, Fermín; Murcia, Óscar; Canelles, Pilar; García López, Santiago; Martín de Argila, Carlos; Planella, Montserrat; Quintana, Manuel; Jericó, Carlos; García Erce, José Antonio. Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts. FRONTIERS IN MEDICINE. 2022. DOI: 10.3389/fmed.2022.903739
  
  
• Domper-Arnal, María José; Hijos-Mallada, Gonzalo; Lanas, Ángel. The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2022. DOI: 10.1177/17562848221117636
  
  
• Gargallo-Puyuelo, C.J.; Lanas, Á.; Carrera-Lasfuentes, P.; Ferrández, Á.; Quintero, E.; Carrillo, M.; Alonso-Abreu, I.; García-González, M.A. Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY. 2021. DOI: 10.14309/ctg.0000000000000301
  
  
• Gisbert J.P.; Alcedo J.; Amador J.; Bujanda L.; Calvet X.; Castro-Fernández M.; Fernández-Salazar L.; Gené E.; Lanas Á.; Lucendo A.J.; Molina-Infante J.; Nyssen O.P.; Pérez-Aisa A.; Puig I. Guía de práctica clínica. V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2021. DOI: 10.17235/reed.2021.8358/2021
  
  
• Mcmahon, S.B.; Dargan, P.; Lanas, A.; Wiffen, P. The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain faculty. CURRENT MEDICAL RESEARCH AND OPINION. 2021. DOI: 10.1080/03007995.2020.1847718
  
  
• Lanas, A. Proton Pump Inhibitor (PPI) co-therapy and gastrointestinal bleeding with antithrombotic drugs: a step forward but not enough. EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2021. DOI: 10.1016/j.ejim.2021.01.014
  
  
• Hunt, R.H.; East, J.E.; Lanas, A.; Malfertheiner, P.; Satsangi, J.; Scarpignato, C.; Webb, G.J. COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. DIGESTIVE DISEASES. 2021. DOI: 10.1159/000512152
  
  
• Gralnek, I.M.; Stanley, A.J.; Morris, A.J.; Camus, M.; Lau, J.; Lanas, A.; Laursen, S.B.; Radaelli, F.; Papanikolaou, I.S.; Cúrdia Gonçalves, T.; Dinis-Ribeiro, M.; Awadie, H.; Braun, G.; de Groot, N.; Udd, M.; Sanchez-Yague, A.; Neeman, Z.; Van Hooft, J.E. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. ENDOSCOPY. 2021. DOI: 10.1055/a-1369-5274
  
  
• Hermoso-Durán, S.; García-Rayado, G.; Ceballos-Laita, L.; Sostres, C.; Vega, S.; Millastre, J.; Sánchez-Gracia, O.; Ojeda, J.L.; Lanas, Á.; Velázquez-Campoy, A.; Abian, O. Thermal liquid biopsy (TLB) focused on benign and premalignant pancreatic cyst diagnosis. JOURNAL OF PERSONALIZED MEDICINE. 2021. DOI: 10.3390/jpm11010025
  
  
• Vennelaganti, S.; Cuatrecasas, M.; Vennalaganti, P.; Kennedy, K.F.; Srinivasan, S.; Patil, D.T.; Plesec, T.; Lanas, A.; Hörndler, C.; Andraws, N.; Cherian, R.; Mathur, S.; Hassan, C.; Repici, A.; Klotz, D.; Musulen, E.; Risio, M.; Castells, A.; Gupta, N.; Sharma, P. Interobserver Agreement Among Pathologists in the Differentiation of Sessile Serrated From Hyperplastic Polyps. GASTROENTEROLOGY. 2021. DOI: 10.1053/j.gastro.2020.09.015
  
  
• Aznar-Gimeno, Rocío; Paño-Pardo, J. Ramón; Esteban, Luis M.; Labata-Lezaun, Gorka; Esquillor-Rodrigo, M. José; Lanas, Angel; Abadía-Gallego, David; Diez-Fuertes, Francisco; Tellería-Orriols, Carlos; Hoyo-Alonso, Rafael Del; Serrano, M. Trinidad. Changes in severity, mortality, and virus genome among a Spanish cohort of patients hospitalized with SARS-CoV-2. SCIENTIFIC REPORTS (NATURE PUBLISHING GROUP). 2021. DOI: 10.1038/s41598-021-98308-x
  
  
• Aznar-Gimeno, Rocío; Esteban, Luis M.; Labata-Lezaun, Gorka; Hoyo-Alonso, Rafael Del; Abadia-Gallego, David; Paño-Pardo, Ramón; Esquillor-Rodrigo, M. José; Lanas, Ángel; Serrano, Trinidad. A clinical decision web to predict ICU admission or death for patients hospitalised with Covid-19 using machine learning algorithms. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021. DOI: 10.3390/ijerph18168677
  
  
• Aznar-Gimeno, R.; Carrera-Lasfuentes, P.; Del-Hoyo-Alonso, R.; Doblare, M.; Lanas, A. Evidence-based selection on the appropriate FIT cut-off point in CRC screening programs in the COVID pandemic. FRONTIERS IN MEDICINE. 2021. DOI: 10.3389/fmed.2021.712040
  
  
• Hijos-Mallada G.; Lué A.; Velamazán R.; Saura N.; Abril C.; Lorenzo M.; Navarro M.; Chueca E.; Arechavaleta S.; Gomollón F.; Lanas Á.; Sostres C. The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort. FRONTIERS IN MEDICINE. 2021. DOI: 10.3389/fmed.2021.665786
  
  
• González, Andrés; Casado, Javier; Lanas, Ángel. Fighting the antibiotic crisis: flavonoids as promising antibacterial drugs against Helicobacter pylori infection. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2021. DOI: 10.3389/fcimb.2021.709749
  
  
• Cañamares-Orbís P.; Lanas Arbeloa Á. New trends and advances in non-variceal gastrointestinal bleeding—series II. JOURNAL OF CLINICAL MEDICINE. 2021. DOI: 10.3390/jcm10143045
  
  
• Domper Arnal, M.J.; García Mateo, S.; Hermoso-Durán, S.; Abad, D.; Carrera-Lasfuentes, P.; Velazquez-Campoy, A.; Abian Franco, O.; Lanas, A. Correction to: False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use (International Journal of Colorectal Disease, (2021), 36, 9, (1861-1869), 10.1007/s00384-021-03947-1). INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2021. DOI: 10.1007/s00384-021-03965-z
  
  
• Contursi, A; Schiavone, S; Dovizio, M; Hinz, C; Fullone, R; Tacconelli, S; Tyrrell, Vj; Grande, R; Lanuti, P; Marchisio, M; Zucchelli, M; Ballerini, P; Lanas Arbelola, A; O''donnell, Vb; Patrignani, P. Platelets induce free and phospholipid-esterified 12-hydroxyeicosatetraenoic acid generation in colon cancer cells by delivering 12-lipoxygenase. JOURNAL OF LIPID RESEARCH. 2021. DOI: 10.1016/j.jlr.2021.100109
  
  
• Hijos-Mallada G.; Velamazán R.; Marti R.; Chueca E.; Arechavaleta S.; Lué A.; Gomollón F.; Lanas A.; Sostres C. A patient self-made point-of-care fecal test improves diagnostic accuracy compared with fecal calprotectin alone in inflammatory bowel disease patients. DIAGNOSTICS. 2021. DOI: 10.3390/diagnostics11122323
  
  
• Biccler, J.; Bollaerts, K.; Vora, P.; Sole, E.; García Rodriguez, L.A.; Lanas, A.; Langley, R.E.; Soriano Gabarró, M. Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK – Results from micro-simulation model. IJC HEART AND VASCULATURE. 2021. DOI: 10.1016/j.ijcha.2021.100851
  
  
• Domper Arnal, M.J.; García Mateo, S.; Hermoso-Durán, S.; Abad, D.; Carrera-Lasfuentes, P.; Velazquez-Campoy, A.; Abian Franco, O.; Lanas, A. False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2021. DOI: 10.1007/s00384-021-03947-1
  
  
• Caldas, M.; Pérez-Aisa, Á.; Castro-Fernández, M.; Bujanda, L.; Lucendo, A.J.; Rodrigo, L.; Huguet, J.M.; Pérez-Lasala, J.; Molina-Infante, J.; Barrio, J.; Fernández-Salazar, L.; Lanas, Á.; Perona, M.; Domínguez-Cajal, M.; Ortuño, J.; Gómez-Rodríguez, B.J.; Almela, P.; Botargués, J.M.; Núñez, Ó.; Modolell, I.; Gómez, J.; Ruiz-Zorrilla, R.; de la Coba, C.; Huerta, A.; Iyo, E.; Pozzati, L.; Antón, R.; Barenys, M.; Angueira, T.; Fernández-Bermejo, M.; Campillo, A.; Alcedo, J.; Pajares-Villaroya, R.; Mego, M.; Bermejo, F.; Dominguez-Jiménez, J.L.; Titó, L.; Fernández, N.; Pabón-Carrasco, M.; Cosme, Á.; Mata-Romero, P.; Alcaide, N.; Ariño, I.; Di Maira, T.; Garre, A.; Puig, I.; Nyssen, O.P.; Megraud, F.; O’morain, C.; Gisbert, J.P. European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain. ANTIBIOTICS. 2021. DOI: 10.3390/antibiotics10010013
  
  
• Tursi, Antonio; Scarpignato, Carmelo; Strate, Lisa L.; Lanas, Ángel; Kruis, Wolfgang; Lahat, Adi; Danese, Silvio. Colonic diverticular disease. NATURE REVIEWS DISEASE PRIMERS. 2020. DOI: 10.1038/s41572-020-0153-5
  
  
• Tursi, A.; Scarpignato, C.; Strate, L.L.; Lanas, A.; Kruis, W.; Lahat, A.; Danese, S. Publisher Correction: Colonic diverticular disease (Nature Reviews Disease Primers, (2020), 6, 1, (20), 10.1038/s41572-020-0153-5). NATURE REVIEWS DISEASE PRIMERS. 2020. DOI: 10.1038/s41572-020-0176-y
  
  
• Hijos Mallada, G.; Abad Baroja, Daniel; Lanas-Gimeno, A.; Lanas Arbeloa, Ángel. Enfermedad ulcerosa péptica. MEDICINE (SPAIN). 2020. DOI: 10.1016/j.med.2020.01.013
  
  
• Tursi, A.; Scarpignato, C.; Strate, L.L.; Lanas, A.; Kruis, W.; Lahat, A.; Danese, S. Author Correction: Colonic diverticular disease (Nature Reviews Disease Primers, (2020), 6, 1, (20), 10.1038/s41572-020-0153-5). NATURE REVIEWS DISEASE PRIMERS. 2020. DOI: 10.1038/s41572-020-0192-y
  
  
• Mcnicholl, A.G.; Garre, A.; Llorca, L.; Bujanda, L.; Molina-Infante, J.; Barenys, M.; Perez, J.; Guerrero-Torres, M.D.; Tamayo, E.; Montes, M.; Prados-Manzano, R.; Sanchez-Garcia, A.; Ramas, M.; Valdez Blanco, V.B.; Montoro, M.; Calvet, X.; Figuerola, A.; Lario, S.; Quilez, E.; Lanas, A.; Silva-Pomarino, P.; Perez-Aisa, A.; Donday, M.G.; Belloc, B.; Montserrat-Torres, A.; Fernandez-Moreno, N.; Ramírez, M.J.; Alarcon, T.; Gisbert, J.P. Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection GASTROENTEROLOGIA Y HEPATOLOGIA. 2020. DOI: 10.1016/j.gastrohep.2019.09.009
  
  
• García-Rayado, G.; Varela-Moreiras, G.; Lanas, Á.; Ferrández, Á.; Balza-Lareu, N.; Cervera, J.I.; Bodenlle-Bello, M.P.; Argüelles-Arias, A.M.; Latorre, P.; Udaondo-Cascante, M.A.; Soria-De-La-Cruz, M.J.; Lariño-Noia, J.; García-Figueiras, R.; Gil-García-Ollauri, C.; Ituarte-Uriarte, R.; Rosales-Alexander, C.L.; Soriano, J.; Rodríguez-Peláez, M.; Mesa-Álvarez, A.; Oblitas, E.; Menso, M.M.; Bertoletti, F.; Rodríguez-Prada, J.I.; Guzmán-Suárez, S.; Closa, D.; De-Madaria, E. Dietary fat patterns and outcomes in acute pancreatitis in Spain. FRONTIERS IN MEDICINE. 2020. DOI: 10.3389/fmed.2020.00126
  
  
• González Rodríguez, Andrés; Casado, Javier; Chueca, Eduardo; Salillas, Sandra; Velázquez-Campoy, Adrián; Sancho, Javier; Lanas, Ángel. Small molecule inhibitors of the response regulator ArsR exhibit bactericidal activity against Helicobacter pylori. MICROORGANISMS. 2020. DOI: 10.3390/microorganisms8040503
  
  
• Cañamares Orbis, P.; Borao Laguna, C.; Sánchez Miguel, L.; /Hijos Mallada, G.; Lanas Arbeloa, A. Hemorragia digestiva alta no varicosa. MEDICINE (SPAIN). 2020. DOI: 10.1016/j.med.2020.01.022
  
  
• Walker, J.; Cattaneo, M.; Badimon, L.; Agnelli, G.; Chan, A.T.; Lanas, A.; Rocca, B.; Rothwell, P.; Patrignani, P.; Langley, R.; Vilahur, G.; Cosentino, F. Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: Benefits and risks of antithrombotic therapy for cardiovascular disease prevention. ECANCERMEDICALSCIENCE. 2020. DOI: 10.3332/ECANCER.2019.998
  
  
• Laredo, Viviana; Sostres, Carlos; Garcia, Sandra; Carrera-Lasfuentes, Patricia; Revilla-Marti, Pablo; Lanas, Ángel. No differences in gastrointestinal bleeding risk among clopidogrel-, ticagrelor-, or prasugrel-based dual antiplatelet therapy. JOURNAL OF CLINICAL MEDICINE. 2020. DOI: 10.3390/jcm9051526
  
  
• Rodriguez, L.A.G.; Lanas, A.; Soriano-Gabarro, M.; Vora, P.; Soriano, L.C. Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study. JOURNAL OF CLINICAL MEDICINE. 2020. DOI: 10.3390/jcm9040928
  
  
• Lué, A.; Hijos, G.; Sostres, C.; Perales, A.; Navarro, M.; Barra, M.V.; Mascialino, B.; Andalucia, C.; Puente, J.J.; Lanas, Á.; Gomollon, F. The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2020. DOI: 10.1177/1756284820920786
  
  
• Navarro, M.; Hijos, G.; Sostres, C.; Lué, A.; Puente-Lanzarote, J.J.; Carrera-Lasfuentes, P.; Lanas, A. Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance. FRONTIERS IN MEDICINE. 2020. DOI: 10.3389/fmed.2020.00410
  
  
• Chueca, E.; Valero, A.; Hördnler, C.; Puertas, A.; Carrera, P.; García-González, M.A.; Strunk, M.; Lanas, A.; Piazuelo, E. Quantitative analysis of p16 methylation in Barrett's carcinogenesis. ANNALS OF DIAGNOSTIC PATHOLOGY. 2020. DOI: 10.1016/j.anndiagpath.2020.151554
  
  
• Tursi, A.; Brandimarte, G.; Di Mario, F.; Lanas, A.; Scarpignato, C.; Bafutto, M.; Barbara, G.; Bassotti, G.; Binda, G. A.; Biondi, A.; Biondo, S.; Cassieri, C.; Crucitti, A.; Dumitrascu, D. L.; Elisei, W.; Escalante, R.; Herszènyi, L.; Kruis, W.; Kupcinskas, J.; Lahat, A.; Lecca, P. G.; Maconi, G.; Malfertheiner, P.; Mazzari, A.; Mearìn, F.; Milosavljevic, T.; Nardone, G.; Chavez de Oliveira, E.; Papa, A.; Papagrigoriadis, S.; Pera, M.; Persiani, R.; Picchio, M.; Regula, J.; Štimac, D.; Stollman, N.; Strate, L. L.; Walker, M. M. The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2020. DOI: 10.15403/jgld-558
  
  
• Cea Soriano, L.; Lanas, A.; Soriano-Gabarró, M.; García Rodríguez, L.A. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019. DOI: 10.1016/j.cgh.2018.05.061
  
  
• Milasavljevic, T.; Brandimarte, G.; Stollman, N.; Barbara, G.; Lahat, A.; Scarpignato, C.; Lanas, A.; Papa, V.; Tursi, A.; Nardone, G. Course of the diverticular disease: What is changing?. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2019. DOI: 10.15403/jgld-552
  
  
• Laredo, V.; Sostres, C.; Alfaro, E.; Arroyo, M.T.; Lanas, Á. Management of Helicobacter pylori infection at the primary care level. The implementation of specific counseling improves eradication rates. HELICOBACTER. 2019. DOI: 10.1111/hel.12586
  
  
• Navarro, M.; Hijos, G.; Ramirez, T.; Omella, I.; Fuentes, P.C.L.; Lanas, A. Faecal haemoglobin concentration, a good predictor of risk of advanced colorectal neoplasia in symptomatic and asymptomatic patients. FRONTIERS IN MEDICINE. 2019. DOI: 10.3389/fmed.2019.00091
  
  
• García Rodríguez, Luis A.; Lanas, Ángel; Soriano-Gabarró, Montse; Cea, Soriano, Lucía. Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom. ANNALS OF MEDICINE. 2019. DOI: 10.1080/07853890.2019.1591635
  
  
• Lanas-Gimeno, Aitor; Hijos, Gonzalo; Lanas, Ángel. Proton pump inhibitors, adverse events and increased risk of mortality. EXPERT OPINION ON DRUG SAFETY. 2019. DOI: 10.1080/14740338.2019.1664470
  
  
• Sostres, Carlos; Marcén, Beatriz; Laredo, Viviana; Alfaro, Enrique; Ruiz, Lara; Camo, Patricia; Carrera-Lasfuentes, Patricia; Lanas, Ángel. Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2019. DOI: 10.1111/apt.15441
  
  
• Caldas, M; Perez-Aisa, A; Castro, M; Bujanda, L; Lucendo, Aj; Fernandez, N; Hinojosa, J; Rodrigo, L; Pabon-Carrasco, M; Ferrer-Barcelo, L; Alonso-Galan, H; Perez-Lasala, J; Molina-Infante, J; Velayos, B; Barrio, J; Lanas, A; Dominguez-Cajal, M; Perona, M; Di Maira, T; Gomez-Rodriguez, Bj; Medina, E; Roldan, M; Mata-Romero, P; Modolell, I; Botargues, J; Jimenez-Moreno, M; Nyssen, Op; Marin, Ac; Donday, Mg; Garre, A; Megraud, F; Morain, Co; Mcnicholl, A; Gisbert, Jp. Efficacy of second-line regimens in SPain: Results from the EuroPean Registry on H. Pylori management (HP-EuReg). HELICOBACTER. 2019
  
  
• Rodrigo, Alberto; Ojeda, Jorge L.; Vega, Sonia; Sanchez-Gracia, Óscar; Lanas, Ángel; Isla, Dolores; Velazquez-Campoy, Adrián; Abian, Olga. Thermal liquid biopsy (Tlb): A predictive score derived from serum thermograms as a clinical tool for screening lung cancer patients. CANCERS. 2019. DOI: 10.3390/cancers11071012
  
  
• Gargallo-Puyuelo, Carla J.; Lanas, Ángel; García-Gonzalez, María Asunción. Adding genetic scores to risk models in colorectal cancer. ONCOTARGET. 2019. DOI: 10.18632/oncotarget.27110
  
  
• González, Andrés;Salillas, Sandra;Velázquez-Campoy, Adrián;Espinosa Angarica, Vladimir;Fillat, María F.;Sancho, Javier;Lanas, Ángel. Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA. SCIENTIFIC REPORTS (NATURE PUBLISHING GROUP). 2019. DOI: 10.1038/s41598-019-47746-9
  
  
• Irun, P.; Lanas, A.; Piazuelo, E. Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review. FRONTIERS IN PHARMACOLOGY. 2019. DOI: 10.3389/fphar.2019.00852
  
  
• Lanas A. Aspirin, cancer, and bleeding: an equation to solve. THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2019. DOI: 10.1016/S2468-1253(19)30290-0
  
  
• Duran-Sanchon, S.; Vila-Navarro, E.; Marcuello, M.; Lozano, J.J.; Muñoz, J.; Cubiella, J.; Diez, M.S.; Bujanda, L.; Lanas, A.; Jover, R.; Hernández, V.; Quintero, E.; Herreros-Villanueva, M.; Martín, A.C.; Pérez-Palacios, R.; Arroyo, R.; Castells, A.; Gironella, M. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients. BIOMOLECULES. 2019. DOI: 10.3390/biom10010016
  
  
• Lanas, A. International consensus guidelines for nonvariceal gastrointestinal bleeding: A step forward. ANNALS OF INTERNAL MEDICINE. 2019. DOI: 10.7326/M19-2789
  
  
• González, Andrés; Casado, Javier; Chueca, Eduardo; Salillas, Sandra; Velázquez-Campoy, Adrián; Espinosa Angarica, Vladimir; Bénejat, Lucie; Guignard, Jérome; Giese, Alban; Sancho, Javier; Lehours, Philippe; Lanas, Ángel. Repurposing dihydropyridines for treatment of helicobacter pylori infection. PHARMACEUTICS. 2019. DOI: 10.3390/pharmaceutics11120681
  
  
• Salillas, Sandra; Alías, Miriam; Michel, Valérie; Mahía, Alejandro; Lucía, Ainhoa; Rodrigues, Liliana; Bueno, Jessica; Galano-Frutos, Juan José; de Reuse, Hilde; Velázquez-Campoy, Adrián; Carrodeguas, José Alberto; Sostres, Carlos; Castillo, Javier; Aínsa. José Antonio; Díaz-De-Villegas, María Dolores; Lanas, Ángel; Touati, Eliette; Sancho, Javier. Design, synthesis, and efficacy testing of nitroethylene- and 7-nitrobenzoxadiazol-based flavodoxin inhibitors against helicobacter pylori drug-resistant clinical strains and in helicobacter pylori-infected mice. JOURNAL OF MEDICINAL CHEMISTRY. 2019. DOI: 10.1021/acs.jmedchem.9b00355
  
  
• Tursi, A.; Brandimarte, G.; Di Mario, F.; Lanas, A.; Scarpignato, C.; Bafutto, M.; Barbara, G.; Bassotti, G.; Binda, G.A.; Biondi, A.; Biondo, S.; Cambie, G.; Cassieri, C.; Crucitti, A.; Dumitrascu, D.L.; Elisei, W.; Escalante, R.; Herszenyi, L.; Kruis, W.; Kupcinskas, J.; Lahat, A.; Lecca, P.G.; Maconi, G.; Malfertheiner, P.; Mazzari, A.; Mearin, F.; Milosavljevic, T.; Nardone, G.; de Oliveira, E.C.; Papa, A.; Papagrigoriadis, S.; Pera, M.; Persiani, R.; Picchio, M.; Regula, J.; Štimac, D.; Stollman, N.; Strate, L.L.; Violi, A.; Walker, M.M.D. International consensus on diverticulosis and diverticular disease. Statements from the 3rd international symposium on diverticular disease. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2019. DOI: 10.15403/jgld-562
  
  
• Herreros-Villanueva, M.; Duran-Sanchon, S.; Martín, A.C.; Pérez-Palacios, R.; Vila-Navarro, E.; Marcuello, M.; Diaz-Centeno, M.; Cubiella, J.; Diez, M.S.; Bujanda, L.; Lanas, A.; Jover, R.; Hernández, V.; Quintero, E.; José Lozano, J.; García-Cougil, M.; Martínez-Arranz, I.; Castells, A.; Gironella, M.; Arroyo, R. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY. 2019. DOI: 10.14309/ctg.0000000000000003
  
  
• Bjarnason, I.; Scarpignato, C.; Holmgren, E.; Olszewski, M.; Rainsford, K.D.; Lanas, A. Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. GASTROENTEROLOGY. 2018. DOI: 10.1053/j.gastro.2017.10.049
  
  
• Gargallo, C.J.; Ferrandez, A.; Carrera, P.; Simon, M.A.; Ducons, J.; Lanas, A. Short- and long-term clinical outcomes of self-expandable metal stents inserted for colorectal obstruction and efficacy of different insertion techniques. GASTROENTEROLOGIA Y HEPATOLOGIA. 2018. DOI: 10.1016/j.gastrohep.2018.07.014
  
  
• González Rodríguez, Andrés; Fillat, María F.; Lanas, Ángel. Transcriptional regulators: valuable targets for novel antibacterial strategies. FUTURE MEDICINAL CHEMISTRY. 2018. DOI: 10.4155/fmc-2017-0181
  
  
• Scally, B.; Emberson, J.R.; Spata, E.; Reith, C.; Davies, K.; Halls, H.; Holland, L.; Wilson, K.; Bhala, N.; Hawkey, C.; Hochberg, M.; Hunt, R.; Laine, L.; Lanas, A.; Patrono, C.; Baigent, C. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2018. DOI: 10.1016/S2468-1253(18)30037-2
  
  
• Bjarnason, I.; Sancak, O.; Crossley, A.; Penrose, A.; Lanas, A. Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulations. JOURNAL OF PHARMACY AND PHARMACOLOGY. 2018. DOI: 10.1111/jphp.12827
  
  
• Lanas, A.; Dumonceau, J.-M.; Hunt, R.H.; Fujishiro, M.; Scheiman, J.M.; Gralnek, I.M.; Campbell, H.E.; Rostom, A.; Villanueva, C.; Sung, J.J.Y. Non-variceal upper gastrointestinal bleeding. NATURE REVIEWS DISEASE PRIMERS. 2018. DOI: 10.1038/nrdp.2018.20
  
  
• Sung, J.J.Y.; Chiu, P.C.Y.; Chan, F.K.L.; Lau, J.Y.W.; Goh, K.L.; Ho, L.H.Y.; Jung, H.Y.; Sollano, J.D.; Gotoda, T.; Reddy, N.; Singh, R.; Sugano, K.; Wu, K.C.; Wu, C.Y.; Bjorkman, D.J.; Jensen, D.M.; Kuipers, E.J.; Lanas, A. Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: An update 2018. GUT. 2018. DOI: 10.1136/gutjnl-2018-316276
  
  
• Solé Llop, María Esther; Cano del Pozo, Mabel; García Montero, José-Ignacio; Carrera-Lasfuentes, Patricia; Lanas, Ángel. Programa de cribado poblacional de cáncer colorrectal en Aragón. Primeros resultados. GACETA SANITARIA. 2018. DOI: 10.1016/j.gaceta.2017.05.014
  
  
• García-Rayado, G.; Lanas, A. Upper gastrointestinal bleeding in critically ill patients: proton-pump inhibitors, histamine-2 receptor antagonists or placebo? Many questions remain unanswered. CURRENT MEDICAL RESEARCH AND OPINION. 2018. DOI: 10.1080/03007995.2018.1510830
  
  
• Gargallo, C.J.; Lanas, Á.; Carrera-Lasfuentes, P.; Ferrandez, Á.; Quintero, E.; Carrillo, M.; Alonso-Abreu, I.; García-Gonzalez, M.A. Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer. INTERNATIONAL JOURNAL OF CANCER. 2018. DOI: 10.1002/ijc.31858
  
  
• Velazquez-Campoy, A.; Vega, S.; Sanchez-Gracia, O.; Lanas, A.; Rodrigo, A.; Kaliappan, A.; Hall, M.B.; Nguyen, T.Q.; Brock, G.N.; Chesney, J.A.; Garbett, N.C.; Abian, O. Thermal liquid biopsy for monitoring melanoma patients under surveillance during treatment: A pilot study. BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS. 2018. DOI: 10.1016/j.bbagen.2018.04.020
  
  
• Garcia-Rayado, G.; Navarro, M.; Lanas, A. NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs. EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2018. DOI: 10.1080/17512433.2018.1516143
  
  
• Mangas-Sanjuan, C.; Zapater, P.; Cubiella, J.; Murcia, Ó.; Bujanda, L.; Hernández, V.; Martínez-Ares, D.; Pellisé, M.; Seoane, A.; Lanas, Á.; Nicolás-Pérez, D.; Herreros-De-Tejada, A.; Chaparro, M.; Cacho, G.; Fernández-Díez, S.; Marín-Gabriel, J.-C.; Quintero, E.; Castells, A.; Jover, R.; Colonprev; Study; Investigators. Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2018. DOI: 10.1177/2050640617745458
  
  
• Elwood, P.C.; Pickering, J.E.; Morgan, G.; Galante, J.; Weightman, A.L.; Morriss, D.; Longley, M.; Mason, M.; Adame, R.; Dolwani, S.; Chia, W.K.J.; Lanas, A. Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?. PLOS ONE. 2018. DOI: 10.1371/journal.pone.0203957
  
  
• Bjarnason, I.; Scarpignato, C.; Rainsford, K.D.; Lanas, A. Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs: What About Perforations and the Healing Intestine? Reply. GASTROENTEROLOGY. 2018. DOI: 10.1053/j.gastro.2018.09.024
  
  
• Sostres, C.; Lanas, A. Low dose aspirin, H. pylori infection, and the risk of upper gastrointestinal bleeding. MEDICAL JOURNAL OF AUSTRALIA. 2018. DOI: 10.5694/mja18.00742
  
  
• Pastushenko, I.; Brisebarre, A.; Sifrim, A.; Fioramonti, M.; Revenco, T.; Boumahdi, S.; Van Keymeulen, A.; Brown, D.; Moers, V.; Lemaire, S.; de Clercq, S.; Minguijon, E.; Balsat, C.; Sokolow, Y.; Dubois, C.; de Cock, F.; Scozzaro, S.; Sopeña, F.; Lanas, A.; D'haene, N.; Salmon, I.; Marine, J.C.; Voet, T.; Sotiropoulou, P.A.; Blanpain, C. Identification of the tumour transition states occurring during EMT. NATURE. 2018. DOI: 10.1038/s41586-018-0040-3
  
  
• Tursi, A.; Scarpignato, C.; Brandimarte, G.; Di Mario, F.; Lanas, A. Rifaximin for the management of colonic diverticular disease: Far beyond a simple antibiotic. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. 2018. DOI: 10.15403/jgld.2014.1121.274.rif
  
  
• Carot, L.; Castells, A.; Hernández, C.; Alvarez-Urturi, C.; Balaguer, F.; Lanas, A.; Cubiella, J.; Tasende, J.D.; Jover, R.; Hernandez, V.; Carballo, F.; Bujanda, L.; Quintero, E.; Andreu, M.; Bessa, X. Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2018. DOI: 10.1177/2050640618804722
  
  
• Lanas, A.; Abad-Baroja, D.; Lanas-Gimeno, A. Progress and challenges in the management of diverticular disease: which treatment?. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2018. DOI: 10.1177/1756284818789055
  
  
• Scarpignato, C.; Barbara, G.; Lanas, A.; Strate, L.L. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2018. DOI: 10.1177/1756284818771305
  
  
• Heinrichs, S.K.M.; Hess, T.; Becker, J.; Hamann, L.; Vashist, Y.K.; Butterbach, K.; Schmidt, T.; Alakus, H.; Krasniuk, I.; Höblinger, A.; Lingohr, P.; Ludwig, M.; Hagel, A.F.; Schildberg, C.W.; Veits, L.; Gyvyte, U.; Weise, K.; Schüller, V.; Böhmer, A.C.; Schröder, J.; Gehlen, J.; Kreuser, N.; Hofer, S.; Lang, H.; Lordick, F.; Malfertheiner, P.; Moehler, M.; Pech, O.; Vassos, N.; Rodermann, E.; Izbicki, J.R.; Kruschewski, M.; Ott, K.; Schumann, R.R.; Vieth, M.; Mangold, E.; Gasenko, E.; Kupcinskas, L.; Brenner, H.; Grimminger, P.; Bujanda, L.; Sopeña, F.; Espinel, J.; Thomson, C.; Pérez-Aísa, Á.; Campo, R.; Geijo, F.; Collette, D.; Bruns, C.; Messerle, K.; Gockel, I.; Nöthen, M.M.; Lippert, H.; Ridwelski, K.; Lanas, A.; Keller, G.; Knapp, M.; Leja, M.; Kupcinskas, J.; García-González, M.A.; Venerito, M.; Schumacher, J. Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome level. CANCER MEDICINE. 2018. DOI: 10.1002/cam4.1719
  
  
• Mearin, F.; Lanas, A.; Bujanda, L.; Canelles, P.; Cotter, J.; Hervas, A.; de Argila, C.M.; Montoro, M.; Gisbert, J.P. Preguntas y errores en el diagnóstico y manejo de la anemia en pacientes con hemorragia digestiva. GASTROENTEROLOGIA Y HEPATOLOGIA. 2018. DOI: 10.1016/j.gastrohep.2017.08.012
  
  
• Patrignani, P; Sacco, A; Sostres, C; Bruno, A; Dovizio, M; Piazuelo, E; Di Francesco, L; Contursi, A; Zucchelli, M; Schiavone, S; Tacconelli, S; Patrono, C; Lanas, A. Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer.. CLINICAL PHARMACOLOGY & THERAPEUTICS. 2017. DOI: 10.1002/cpt.639
  
  
• Halvorsen, S.; Storey, R.F.; Rocca, B.; Sibbing, D.; Berg, J.T.; Grove, E.L.; Weiss, T.W.; Collet, J.-P.; Andreotti, F.; Gulba, D.C.; Lip, G.Y.H.; Husted, S.; Vilahur, G.; Morais, J.; Verheugt, F.A.; Lanas, A.; Salman, R.A.-S.; Steg, P.G.; Huber, K. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: Expert consensus paper of the European Society of cardiology working group on thrombosis. EUROPEAN HEART JOURNAL. 2017. DOI: 10.1093/eurheartj/ehw454
  
  
• Navarro, M.; Nicolas, A.; Ferrandez, A.; Lanas, A. Colorectal cancer population screening programs worldwide in 2016: An update. WORLD JOURNAL OF GASTROENTEROLOGY. 2017. DOI: 10.3748/wjg.v23.i20.3632
  
  
• Jiménez, Pilar; Chueca, Eduardo; Arruebo, María; Strunk, Mark; Solanas, Estela; Serrano, Trinidad; García-González, María A.; Lanas, Ángel. CD24 expression is increased in 5-fluorouracil-treated esophageal adenocarcinoma cells. FRONTIERS IN PHARMACOLOGY. 2017. DOI: 10.3389/fphar.2017.00321
  
  
• Scarpignato, C.; Dolak, W.; Lanas, A.; Matzneller, P.; Renzulli, C.; Grimaldi, M.; Zeitlinger, M.; Bjarnason, I. Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans. GASTROENTEROLOGY. 2017. DOI: 10.1053/j.gastro.2016.12.007
  
  
• García-Rayado, G.; Sostres, C.; Lanas, A. Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers. EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2017. DOI: 10.1080/17512433.2017.1324782
  
  
• Scarpignato, Carmelo; Lanas, Angel; Bjarnason, Ingvar. Reply. GASTROENTEROLOGY. 2017. DOI: 10.1053/j.gastro.2017.06.047
  
  
• Sostres, C.; Carrera-Lasfuentes, P.; Lanas, A. Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practice. CURRENT MEDICAL RESEARCH AND OPINION. 2017. DOI: 10.1080/03007995.2017.1338178
  
  
• García Rodríguez, L.A.; Soriano-Gabarró, M.; Bromley, S.; Lanas, A.; Cea Soriano, L. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: A nested case-control study in UK general practice. BMC CANCER. 2017. DOI: 10.1186/s12885-017-3594-9
  
  
• Gisbert, J.P.; Molina-Infante, J.; Amador, J.; Bermejo, F.; Bujanda, L.; Calvet, X.; Castro-Fernández, M.; Cuadrado-Lavín, A.; Elizalde, J.I.; Gene, E.; Gomollón, F.; Lanas, Á.; de Argila, C.M.; Mearin, F.; Montoro, M.; Pérez-Aisa, Á.; Pérez-Trallero, E.; Mcnicholl, A.G. Fe de errores de «IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori» <(Gastroenterol Hepatol (2016)39 (697–721) (S0210570516300589) (10.1016/j.gastrohep.2016.05.003)). GASTROENTEROLOGIA Y HEPATOLOGIA. 2017. DOI: 10.1016/j.gastrohep.2017.02.004
  
  
• Cubiella, J.; Castells, A.; Andreu, M.; Bujanda, L.; Carballo, F.; Jover, R.; Lanas, Á.; Morillas, J. D.; Salas, D.; Quintero, E.; On Behalf Of The Colonprev, Study Investigators; Lanas, A.; González-Rubio, F.; Moya-Calvo, A.; Polo-Tomas, M.; Roncales, M. P.; Sebastian-Martínez, P.; Valencia-Doblas, M.; Valero-Capilla, N.; Alkiza, M. E.; Altzibar, J.; Amiano, P.; Arenas, J.; Artiñano, E.; Cosme, A.; Egitegi, I.; Elorriaga, K.; Elósegui, J. L.; Enriquez-Navascués, J. M.; Erce, C.; Gil, I.; Gutiérrez-Stampa, M. A.; Herreros, M.; Hijona, E.; Jaúregui, M.; Laredo, E.; Martínez, R.; Mitxelena, M. J.; Montalvo, I.; Placer, C.; Portillo, I.; Sarasqueta, C.; Alarcón, O.; Alonso-Abreu, I.; Carrillo-Palau, M.; De, La Vega; Díez-Fuentes, M. L.; Gimeno-García, A.; González-Méndez, Y.; Hernández-Guerra, M.; Linertová, R.; Nicolás-Perez, D.; Reyes-Melián, J. M.; Álvarez, C.; Augé, J. M.; Balaguer, F.; Barau, M.; Bessa, X.; Bory, F.; Burón, A.; Castells, X.; Comas, M.; Cuatrecasas, M.; Estrada, M.; Ferrer, O.; Garrell, I.; Grau, J.; Guayta, R.; Hernández, C.; López-Cerón, M.; Macià, F.; Moreira, L.; Ocaña, T.; Pellisé, M.; Piracés, M.; Polbach, S.; Pozo, À.; Puigvehí, M.; Rodríguez, C.; Sala, M.; Seoane, A.; Serradesanferm, A.; Sivilla, J.; Trilla, A.; Belén Aguado, M.; Aldecoa, S.; Almazán, R.; Alonso, A.; Castro, I.; Cid, E.; Cid, L.; Clofent, J.; Luisa, de Castro; Estévez, P.; Fernández, A. B.; Dolores González, M.; González, S.; González-Mao, M. C.; Hernández, V.; Iglesias, B.; Iglesias, F.; Iglesias, P.; López-Martínez, Á.; Macenlle, R.; Martínez, A.; Martínez, D.; Menéndez, C.; Méndez, C.; Hermo, J. A.; Pérez, I.; Portasany, C.; Rionda, M.; Rivera, C.; Rodríguez, B.; Rodríguez, R.; Rubio, M.; Santiago, M. I.; Vázquez, M.; Vázquez, J. Á.; Vega, P.; Vidal, M. C.; Zubizarreta, R.; Abreu, L.; Amador, F. J.; Barba, M.; Blanco, J. M.; Cacho, G.; Cantero, J.; Carrasco, J.; Carrascosa, B.; Chaparro, M.; Díaz-Tasende, J.; Domínguez, N.; Esteban, J. M.; Fernández, C.; Fernández, C.; Fernández-Díez, S.; Fernández-Gil, M.; Ferrándiz, J.; Garrido, A.; Gisbert, J. P.; Gómez-Molíns, I.; González, M. J.; Guardiola, J.; Herreros, A.; Iglesias, R.; Izquierdo, S.; López, C.; Marín, A.; Marín, J. C.; Martín, D.; Luis Martínez, J.; Moreno, J. A.; Moreno, J. M.; Moreno, R.; Nogueiras, A.; Pérez, M. T.; Plaza, C.; Polentinos, E.; Poves, C.; Pozo, A. D.; Salces, I.; Sánchez, F.; Sánchez-Ceballos, F.; Santander, C.; Sastre, R.; Tahsin, S.; Valentín, V.; Alajarín, M.; Alberca, F.; Bermejo, J.; Carrillo, J.; Cruzado, J.; López, P.; Martínez, M.; Navarro, M. D.; Ono, A.; Parra, S.; Pérez-Riquelme, F.; Riquelme, P.; Andrés, M.; Calvo, C.; Jimenez, M.; Málaga, A.; Pérez, E.; Peris, A.; Ponce, M.; Sala, T.; Teruel, G. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2017. DOI: 10.1177/2050640616660662
  
  
• Neira, J.L.; Bintz, J.; Arruebo, M.; Rizzuti, B.; Bonacci, T.; Vega, S.; Lanas, A.; Velázquez-Campoy, A.; Iovanna, J.L.; Abián, O. Identification of a Drug Targeting an Intrinsically Disordered Protein Involved in Pancreatic Adenocarcinoma. SCIENTIFIC REPORTS (NATURE PUBLISHING GROUP). 2017. DOI: 10.1038/srep39732
  
  
• Lanas, A.; Chan, F.K.L. Peptic ulcer disease. THE LANCET. 2017. DOI: 10.1016/S0140-6736(16)32404-7
  
  
• Carrera-Lasfuentes, Patricia; Lanas, Angel; Bujanda, Luis; Strunk, Mark; Quintero, Enrique; Santolaria, Santos; Benito, Rafael; Sopeña, Federico; Piazuelo, Elena; Thomson, Concha; Pérez-Aisa, Angeles; Nicolás-Pérez, David; Hijona, Elizabeth; Espinel, Jesús; Rafael Campo; Marisa Manzano; Fernando Geijo; María Pellise; Manuel Zaballa; González-Huix, Ferrán; Espinós, Jorge; Titó, Llúcia; Barranco, Luis; D’amato, Mauro; García-González, María Asunción. Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype. ONCOTARGET. 2017. DOI: 10.18632/oncotarget.16261
  
  
• Lanas, A. A Few Spanish Pearls for the American Journal of Gastroenterology. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017. DOI: 10.1038/ajg.2017.410
  
  
• Gisbert, J.P.; Molina-Infante, J.; Amador, J.; Bermejo, F.; Bujanda, L.; Calvet, X.; Castro-Fernandez, M.; Cuadrado-Lavin, A.; Elizalde, J.I.; Gene, E.; Gomollon, F.; Lanas, A.; de Argila, C.M.; Mearin, F.; Montoro, M.; Perez-Aisa, A.; Perez-Trallero, E.; Mcnicholl, A.G. Fe de errores de «Unidades multidisciplinarias en hospitales de referencia para mejorar la atención de los pacientes con enfermedad de Wilson» <[Gastroenterol Hepatol 39 (2016) 571–573]>. GASTROENTEROLOGIA Y HEPATOLOGIA. 2017. DOI: 10.1016/j.gastrohep.2017.02.005
  
  
• Lanas-Gimeno, A.; Lanas, A. Risk of gastrointestinal bleeding during anticoagulant treatment. EXPERT OPINION ON DRUG SAFETY. 2017. DOI: 10.1080/14740338.2017.1325870
  
  
• Sostres,C.;Lanas,Á. Prescripción apropiada, adherencia y seguridad de los antiinflamatorios no esteroideos. MEDICINA CLINICA. 2016. DOI: 10.1016/j.medcli.2015.09.022
  
  
• Lue, A.; Laredo, V.; Lanas, A. Medical Treatment of Diverticular Disease Antibiotics. JOURNAL OF CLINICAL GASTROENTEROLOGY. 2016. DOI: 10.1097/MCG.0000000000000593
  
  
• Lanas, A. We are using too many PPIs, and we need to stop: A European perspective. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2016. DOI: 10.1038/ajg.2016.166
  
  
• Rodríguez, L.A.G.; Martín-Pérez, M.; Hennekens, C.H.; Rothwell, P.M.; Lanas, A. Bleeding risk with long-term low-dose aspirin: A systematic review of observational studies. PLOS ONE. 2016. DOI: 10.1371/journal.pone.0160046
  
  
• Goldstein, J.L.; Whellan, D.J.; Scheiman, J.M.; Cryer, B.L.; Eisen, G.M.; Lanas, A.; Fort, J.G. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk. CARDIOVASCULAR THERAPEUTICS. 2016. DOI: 10.1111/1755-5922.12172
  
  
• Jover, R.; Zapater, P.; Bujanda, L.; Hernández, V.; Cubiella, J.; Pellisé, M.; Ponce, M.; Ono, A.; Lanas, A.; Seoane, A.; Marín-Gabriel, J. C.; Chaparro, M.; Cacho, G.; Herreros-De-Tejada, A.; Fernández-Díez, S.; Peris, A.; Nicolás-Pérez, D.; Murcia, O.; Castells, A.; Quintero, E. Endoscopist characteristics that influence the quality of colonoscopy. ENDOSCOPY. 2016. DOI: 10.1055/s-0042-100185
  
  
• Forder, S.; Voelker, M.; Lanas, A. Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized Controlled Trials. DRUGS IN R&D. 2016. DOI: 10.1007/s40268-016-0138-8
  
  
• Piazuelo, E.; Esquivias, P.; Martino, A. De; Cebrián, C.; Conde, B.; Santander, S.; Emperador, S.; García-González, M.A.; Carrera-Lasfuentes, P.; Lanas, A. Acetylsalicylic Acid Exhibits Antitumor Effects in Esophageal Adenocarcinoma Cells In Vitro and In Vivo. DIGESTIVE DISEASES AND SCIENCES. 2016. DOI: 10.1007/s10620-016-4225-z
  
  
• Vaduganathan, M.; Cannon, C. P.; Cryer, B. L.; Liu, Y.; Hsieh, W. -H; Doros, G.; Cohen, M.; Lanas, A.; Schnitzer, T. J.; Shook, T. L.; Lapuerta, P.; Goldsmith, M. A.; Laine, L.; Bhatt, D. L. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial. AMERICAN JOURNAL OF MEDICINE. 2016. DOI: 10.1016/j.amjmed.2016.03.042
  
  
• Alvarez-Urturi,C.;Andreu,M.;Hernandez,C.;Perez-Riquelme,F.;Carballo,F.;Ono,A.;Cruzado,J.;Cubiella,J.;Hernandez,V.;Mao,C. G.;Perez,E.;Salas,D.;Andrés,M.;Bujanda,L.;Portillo,I.;Sarasqueta,C.;Quintero,E.;Morillas,J. D.;Lanas,A.;Sostres,C.;Augé,J. M.;Castells,A.;Bessa,X. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening. DIGESTIVE AND LIVER DISEASE. 2016. DOI: 10.1016/j.dld.2016.02.001
  
  
• Bhatt,D. L.;Cryer,B. L.;Liu,Y.;Hsieh,W. -H;Doros,G.;Cohen,M.;Lanas,A.;Schnitzer,T. J.;Shook,T. L.;Lapuerta,P.;Goldsmith,M. A.;Laine,L.;Cannon,C. P. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2016. DOI: 10.1016/j.jacc.2015.12.068
  
  
• Quintero, E.; Carrillo, M.; Leoz, M.L; Cubiella, J.; Gargallo, C.; Lanas, A.; Bujanda, L.; Gimeno-García, A.Z.; Hernández-Guerra, M.; Nicolás-Pérez, D.; Alonso-Abreu, I.; Morillas, J.D.; Balaguer, F.; Muriel, A. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLOS MEDICINE. 2016. DOI: 10.1371/journal.pmed.1002008
  
  
• Marcén, B.; Sostres, C.; Lanas, A. AINE y riesgo digestivo. ATENCION PRIMARIA. 2016. DOI: 10.1016/j.aprim.2015.04.008
  
  
• Elwood, P.C.; Morgan, G.; Galante, J.; Chia, J.W.K.; Dolwani, S.; Graziano, J.M.; Kelson, M.; Lanas, A.; Longley, M.; Phillips, C.J.; Pickering, J.; Roberts, S.E.; Soon, S.S.; Steward, W.; Morris, D.; Weightman, A.L. Systematic review and meta-analysis of randomised trials to ascertain fatal gastrointestinal bleeding events attributable to preventive low-dose aspirin: No evidence of increased risk. PLOS ONE. 2016. DOI: 10.1371/journal.pone.0166166
  
  
• Chueca, E.; Apostolova, N.; Esplugues, J.V.; García-González, M.A.; Lanas, Á.; Piazuelo, E. Proton pump inhibitors display antitumor effects in barrett's adenocarcinoma cells. FRONTIERS IN PHARMACOLOGY. 2016. DOI: 10.3389/fphar.2016.00452
  
  
• Gisbert, J. P.; Molina-Infante, J.; Amador, J.; Bermejo, F.; Bujanda, L.; Calvet, X.; Castro-Fernández, M.; Cuadrado-Lavín, A.; Elizalde, J. I.; Gene, E.; Gomollón, F.; Lanas, Á.; Martín, de Argila; Mearin, F.; Montoro, M.; Pérez-Aisa, Á.; Pérez-Trallero, E.; Mcnicholl, A. G. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori GASTROENTEROLOGIA Y HEPATOLOGIA. 2016. DOI: 10.1016/j.gastrohep.2016.05.003
  
  
• Lanas, Ángel. Avances en hemorragia gastrointestinal GASTROENTEROLOGIA Y HEPATOLOGIA. 2016. DOI: 10.1016/S0210-5705(16)30175-3
  
  
• Lué, A.; Lanas, A. Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits. WORLD JOURNAL OF GASTROENTEROLOGY. 2016. DOI: 10.3748/wjg.v22.i48.10477
  
  
• Lanas, A. Prevention of rebleeding: High-dose PPIs, second-look endoscopy or both?. ENDOSCOPY. 2016. DOI: 10.1055/s-0042-111001
  
  
• Lanas,A.; Boers,M.; Nuevo,J. Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: The EVIDENCE study of European routine practice. ANNALS OF THE RHEUMATIC DISEASES. 2015. DOI: 10.1136/annrheumdis-2013-204155
  
  
• Lanas, A.;Carrera-Lasfuentes, P.;Arguedas, Y.;García, S.;Bujanda, L.;Calvet, X.;Ponce, J.;Perez-Aísa, T.;Castro, M.;Muñoz, M.;Sostres, C.;García-Rodríguez, L. A. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2015. DOI: 10.1016/j.cgh.2014.11.007
  
  
• Sostres, C.;Carrera-Lasfuentes, P.;Benito, R.;Roncales, P.;Arruebo, M.;Arroyo, M. T.;Bujanda, L.;Garciá-Rodríguez, L. A.;Lanas, A. Peptic ulcer bleeding risk. the role of helicobacter pylori infection in NSAID/low-dose aspirin users. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2015. DOI: 10.1038/ajg.2015.98
  
  
• Claveria-Gimeno, R.; Vega, S.; Grazu, V.; de la Fuente, J.M.; Lanas, A.; Velazquez-Campoy, A.; Abian, O. Rescuing compound bioactivity in a secondary cell-based screening by using gamma-cyclodextrin as a molecular carrier. INTERNATIONAL JOURNAL OF NANOMEDICINE. 2015. DOI: 10.2147/IJN.S79480
  
  
• Lanas, A.;Gargallo, C. J. Management of low-dose aspirin and clopidogrel in clinical practice: A gastrointestinal perspective. JOURNAL OF GASTROENTEROLOGY. 2015. DOI: 10.1007/s00535-015-1038-3
  
  
• García-González, M. A.; Bujanda, L.; Quintero, E.; Santolaria, S.; Benito, R.; Strunk, M.; Sopeña, F.; Thomson, C.; Pérez-Aisa, A.; Nicolás-Pérez, D.; Hijona, E.; Carrera-Lasfuentes, P.; Piazuelo, E.; Jiménez, P.; Espinel, J.; Campo, R.; Manzano, M.; Geijo, F.; Pellise, M.; Zaballa, M.; González-Huix, F.; Espinõs, J.; Titõ, L.; Barranco, L.; Pazo-Cid, R.; Lanas, A. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease. INTERNATIONAL JOURNAL OF CANCER. 2015. DOI: 10.1002/ijc.29500
  
  
• Vega, S.; Garcia-Gonzalez, M.; Lanas, A.; Velazquez-Campoy, A.; Abian, O. Deconvolution analysis for classifying gastric adenocarcinoma patients based on differential scanning calorimetry serum thermograms. SCIENTIFIC REPORTS (NATURE PUBLISHING GROUP). 2015. DOI: 10.1038/srep07988
  
  
• Gralnek, I. M.; Dumonceau, J. -M; Kuipers, E. J.; Lanas, A.; Sanders, D. S.; Kurien, M.; Rotondano, G.; Hucl, T.; Dinis-Ribeiro, M.; Marmo, R.; Racz, I.; Arezzo, A.; Hoffmann, R. -T; Lesur, G.; de Franchis, R.; Aabakken, L.; Veitch, A.; Radaelli, F.; Salgueiro, P.; Cardoso, R.; Maia, L.; Zullo, A.; Cipolletta, L.; Hassan, C. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. ENDOSCOPY. 2015. DOI: 10.1055/s-0034-1393172
  
  
• Vardi, M.; Cryer, B. L.; Cohen, M.; Lanas, A.; Schnitzer, T. J.; Lapuerta, P.; Goldsmith, M. A.; Laine, L.; Doros, G.; Liu, Y.; Mcintosh, A. I.; Cannon, C. P.; Bhatt, D. L. The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: Analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2015. DOI: 10.1111/apt.13260
  
  
• Gargallo Puyuelo, C. J.; Sopeña, F.; Lanas Arbeloa, A. Colonic diverticular disease. Treatment and prevention. GASTROENTEROLOGIA Y HEPATOLOGIA. 2015. DOI: 10.1016/j.gastrohep.2015.03.010
  
  
• Lanas, A.; Carrera, P.; Bujanda, L.; Garcia-Rodriguez, L. Reply. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2015. DOI: 10.1016/j.cgh.2015.07.022
  
  
• Piazuelo, E.; Lanas, A. NSAIDS and gastrointestinal cancer. PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2015. DOI: 10.1016/j.prostaglandins.2015.06.001
  
  
• Domper Arnal, M.J.; Fernandez Arenas, Á.; Lanas Arbeloa, Á. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. WORLD JOURNAL OF GASTROENTEROLOGY. 2015. DOI: 10.3748/WJG.v21.i26.7933
  
  
• Capel, M.; Tornero, J.; Zamorano, J. L.; Oyagüez, I.; Casado, M. T.; Sánchez-Covisa, J.; Lanas, A. Eficiencia de la combinación naproxeno/esomeprazol para el tratamiento de la artrosis en España; Scopus. REUMATOLOGIA CLINICA. 2014. DOI: 10.1016/j.reuma.2013.11.009
  
  
• Lanas, A.; Benito, P.; Alonso, J.; Hernández-Cruz, B.; Barón-Esquivias, G.; Perez-Aísa, T.; Calvet, X.; García-Llorente, J. F.; Gobbo, M.; Gonzalez-Juanatey, J. Recomendaciones para una prescripción segura de antiinflamatorios no esteroideos: Documento de consenso elaborado por expertos nominados por 3 sociedades científicas (SER-SEC-AEG); Scopus. GASTROENTEROLOGIA Y HEPATOLOGIA. 2014. DOI: 10.1016/j.gastrohep.2013.11.014
  
  
• Patrignani,P.; Tacconelli,S.; Piazuelo,E.; Di Francesco,L.; Dovizio,M.; Sostres,C.; Marcantoni,E.; Guillem-Llobat,P.; del Boccio,P.; Zucchelli,M.; Patrono,C.; Lanas,A. Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2014. DOI: 10.1111/jth.12637
  
  
• Esquivias, P.; Cebrián, C.; Morandeira, A.; Santander, S.; Ortego, J.; García-González, M. A.; Lanas, A.; Piazuelo, E. Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model. ONCOLOGY REPORTS. 2014. DOI: 10.3892/or.2014.3137
  
  
• Salas,D.; Vanaclocha,M.; Ibáñez,J.; Molina-Barceló,A.; Hernández,V.; Cubiella,J.; Zubizarreta,R.; Andreu,M.; Hernández,C.; Pérez-Riquelme,F.; Cruzado,J.; Carballo,F.; Bujanda,L.; Sarasqueta,C.; Portillo,I.; Vega,de La; Morillas,J. D.; Valentín,V.; Lanas,Á.; Quintero,E.; Castells,A. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. CANCER CAUSES & CONTROL. 2014. DOI: 10.1007/s10552-014-0398-y
  
  
• Caralt,M.; Velasco,E.; Lanas,A.; Baptista,P. M. Liver bioengineering: From the stage of liver decellularized matrix to the multiple cellular actors and bioreactor special effects. ORGANOGENESIS. 2014. DOI: 10.4161/org.29892
  
  
• García-González,M. A.; Lanas,A. Genetic susceptibility and gastric cancer risk: The importance of meta-analyses as a statistical tool. GASTROENTEROLOGIA Y HEPATOLOGIA. 2014. DOI: 10.1016/j.gastrohep.2014.01.007
  
  
• Bujanda, L.; Sarasqueta, C.; Lanas, Á.; Quintero, E.; Cubiella, J.; Hernandez, V.; Morillas, J.D.; Perez-Fernández, T.; Salas, D.; Andreu, M.; Carballo, F.; Bessa, X.; Portillo, I.; Jover, R.; Balaguer, F.; Cosme, A.; Castells, A. Effect of oral anticoagulants on the outcome of faecal immunochemical test. BRITISH JOURNAL OF CANCER. 2014. DOI: 10.1038/bjc.2014.38
  
  
• Lanas,A. Hemorragia gastrointestinal, antiinflamatorios no esteroideos, ácido acetilsalicílico y anticoagulantes. GASTROENTEROLOGIA Y HEPATOLOGIA. 2014. DOI: 10.1016/S0210-5705(14)70084-6
  
  
• Sostres,C.; Gargallo,C. J.; Lanas,A. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: Old question new insights. WORLD JOURNAL OF GASTROENTEROLOGY. 2014. DOI: 10.3748/wjg.v20.i28.9439
  
  
• Castells,A.; Quintero,E.; Álvarez,C.; Bujanda,L.; Cubiella,J.; Salas,D.; Lanas,A.; Carballo,F.; Morillas,J. D.; Hernández,C.; Jover,R.; Hijona,E.; Portillo,I.; Enríquez-Navascués,J. M.; Hernández,V.; Martínez-Turnes,A.; Menéndez-Villalva,C.; González-Mao,C.; Sala,T.; Ponce,M.; Andrés,M.; Teruel,G.; Peris,A.; Sopeña,F.; González-Rubio,F.; Seoane-Urgorri,A.; Grau,J.; Serradesanferm,A.; Pozo,T.; Pellisé,M.; Balaguer,F.; Ono,A.; Cruzado,J.; Pérez-Riquelme,F.; Alonso-Abreu,I.; Carrillo-Palau,M.; De,La Vega; Iglesias,R.; Amador,J.; Blanco,J. M.; Sastre,R.; Ferrándiz,J.; González-Hernández,M. J.; Andreu,M.; Bessa,X.; Lanas,A.; González-Rubio,F.; Moya-Calvo,A.; Polo-Tomas,M.; Roncales,M. P.; Sebastian-Martínez,M.; Valencia-Doblas,M.; Valero-Capilla,N.; Alkiza,M. E.; Altzibar,J.; Amiano,P.; Arenas,J.; Artiñano,E.; Cosme,A.; Egitegi,I.; Elorriaga,K.; Elósegui,J. L.; Enriquez-Navascués,J. M.; Erce,C.; Gil,I.; Gutiérrez-Stampa,M. A.; Herreros,M.; Jaúregui,M.; Laredo,E.; Martínez,R.; Mitxelena,M. J.; Montalvo,I.; Placer,C.; Sarasqueta,C.; Alarcón,O.; De,La Vega; Díez-Fuentes,M. L.; Gimeno-García,A.; González-Méndez,Y.; Hernández-Guerra,M.; Linertová,R.; Nicolás-Perez,D.; Reyes- Melián,J. M.; Augé,J. M.; Barau,M.; Bory,F.; Burón,A.; Castells,X.; Comas,M.; Cuatrecasas,M.; Estrada,M.; Ferrer,O.; Garrell,I.; Guayta,R.; López-Cerón,M.; Macià,F.; Moreira,L.; Ocaña,T.; Piracés,M.; Polbach,S.; Pozo,A.; Puigvehí,M.; Rodríguez,C.; Sala,M.; Seoane,A.; Sivilla,J.; Trilla,A.; Aguado,M. B.; Aldecoa,S.; Almazán,R.; Alonso,A.; Castro,I.; Cid,E.; Cid,L.; Clofent,J.; de Castro,M. L.; Estévez,P.; Fernández,A. B.; González,M. D.; González,S.; González-Mao,M. C.; Hernández,V.; Iglesias,B.; Iglesias,F.; Iglesias,P.; López-Martínez,A.; Macenlle,R.; Martínez,A.; Martínez,D.; Menéndez,C.; Méndez,C.; Hermo,J. A.; Pérez,I.; Portasany,C.; Rionda,M.; Rivera,C.; Rodríguez,B.; Rodríguez,R.; Rubio,M.; Isolina Santiago,M.; Vázquez,M.; Vázquez,J. A.; Vega,P.; Vidal,M. C.; Zubizarreta,R.; Abreu,L.; Amador,F. J.; Barba,M.; Cacho,G.; Cantero,J.; Carrasco,J.; Carrascosa,B.; Chaparro,M.; Díaz-Tasende,J.; Domínguez,N.; Esteban,J. M.; Fernández,C.; Fernández,C.; Fernández-Díez,S.; Fernández-Gil,M.; Garrido,A.; Gisbert,J. P.; Gómez-Molíns,I.; González,M. J.; Guardiola,J.; Herreros,A.; Izquierdo,S.; López,C.; Marín,A.; Marín,J. C.; Martín,D.; Martínez,J. L.; Moreno,J. A.; Moreno,J. M.; Moreno,R.; Nogueiras,A.; Pérez,M. T.; Plaza,C.; Polentinos,E.; Poves,C.; del Pozo,A.; Salces,I.; Sánchez,F.; Sánchez-Ceballos,F.; Santander,C.; Tahsin,S.; Valentín,V.; Alajarín,M.; Alberca,F.; Bermejo,J.; Carrillo,J.; López,P.; Martínez,M.; Navarro,M. D.; Parra,S.; Riquelme,P.; Andrés,M.; Calvo,C.; Jimenez,M.; Málaga,A.; Pérez,E. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2014. DOI: 10.1016/j.cgh.2014.03.022
  
  
• Lanas,A.; Carrera-Lasfuentes,P.; García-Rodríguez,L. A.; García,S.; Arroyo-Villarino,M.; Ponce,J.; Bujanda,L.; Calleja,J. L.; Polo-Tomas,M.; Calvet,X.; Feu,F.; Perez-Aisa,A. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high-or low-risk stigmata. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2014. DOI: 10.3109/00365521.2014.950694
  
  
• Moran, E. C.; Dhal, A.; Vyas, D.; Lanas, A.; Soker, S.; Baptista, P. M. Whole-organ bioengineering: Current tales of modern alchemy. TRANSLATIONAL RESEARCH. 2014. DOI: 10.1016/j.trsl.2014.01.004
  
  
• Baron, J.A.; Senn, S.; Voelker, M.; Lanas, A.; Laurora, I.; Thielemann, W.; Brückner, A.; Mccarthy, D. Gastrointestinal adverse effects of short-term aspirin use: A meta-analysis of published randomized controlled trials. DRUGS IN R&D. 2013. DOI: 10.1007/s40268-013-0011-y
  
  
• Pérez Aisa, T.;Lanas Arbeloa, A. Carta respuesta. GASTROENTEROLOGIA Y HEPATOLOGIA. 2013. DOI: 10.1016/j.gastrohep.2012.11.003
  
  
• Álvarez, C.;Andreu, M.;Castells, A.;Quintero, E.;Bujanda, L.;Cubiella, J.;Salas, D.;Lanas, Á.;Carballo, F.;Morillas, J. D.;Hernández, C.;Jover, R.;Sarasqueta, C.;Enriquéz-Navascués, J. M.;Hernández, V.;Estévez, P.;Macenlle, R.;Sala, T.;Balaguer, F.;Pellisé, M.;Moreira, L.;Gil, I.;Peris, A.;González-Rubio, F.;Ferrández, Á.;Poves, C.;Ponce, M.;Grau, J.;Serradesanferm, A.;Ono, A.;Cruzado, J.;Pérez-Riquelme, F.;Alonso-Abreu, I.;Carrillo-Palau, M.;Santander, C.;Díaz Tasende, J.;Herreros, A.;Cacho, G.;Barranco, L. E.;Bessa, X. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. GASTROINTESTINAL ENDOSCOPY. 2013. DOI: 10.1016/j.gie.2013.03.003
  
  
• Lanas, A. Compliance With Prescriptions of Appropriate Therapy for Nonsteroidal Anti-inflammatory Drug Users: Is the Glass Half Empty or Half Full?. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2013. DOI: 10.1016/j.cgh.2013.01.011
  
  
• Lanas, Ángel. Actualización en enfermedad gastrointestinal relacionada con antiinflamatorios no esteroideos. GASTROENTEROLOGIA Y HEPATOLOGIA. 2013. DOI: 10.1016/S0210-5705(08)76627-5
  
  
• Lanas, A.;Polo-Tomás, M.;Casado-Arroyo, R. Letter: The burden of co-morbidity in the population contributes more to upper gastrointestinal bleeding than aspirin - Authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2013. DOI: 10.1111/apt.12320
  
  
• Bujanda, L.;Lanas, Á.;Quintero, E.;Castells, A.;Sarasqueta, C.;Cubiella, J.;Hernandez, V.;Morillas, J. D.;Perez-Fernández, T.;Salas, D.;Andreu, M.;Carballo, F.;Bessa, X.;Cosme, A.;Jover, R. Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test. MAYO CLINIC PROCEEDINGS. 2013. DOI: 10.1016/j.mayocp.2013.04.016
  
  
• Casado-Arroyo, R.;Sostres, C.;Lanas, A. Optimizing the use of aspirin for cardiovascular prevention. DRUGS. 2013. DOI: 10.1007/s40265-013-0061-z
  
  
• de Groot, N. L.;Van Haalen, H. G. M.;Spiegel, B. M. R.;Laine, L.;Lanas, A.;Focks, J. J.;Siersema, P. D.;Van Oijen, M. G. H. Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: Results of a cost-effectiveness analysis including compliance. CARDIOVASCULAR DRUGS AND THERAPY. 2013. DOI: 10.1007/s10557-013-6448-y
  
  
• Gargallo, C. J.;Lanas, A. Importance of adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment. ANNALS OF GASTROENTEROLOGY. 2013
  
  
• Gisbert, J. P.;Calvet, X.;Bermejo, F.;Boixeda, D.;Bory, F.;Bujanda, L.;Castro-Fernández, M.;Dominguez-Muñoz, E.;Elizalde, J. I.;Forn, M.;Gené, E.;Gomollón, F.;Lanas, A.;Martín, de Argila;Mcnicholl, A. G.;Mearin, F.;Molina-Infante, J.;Montoro, M.;Pajares, J. M.;Pérez-Aisa, A.;Pérez-Trallero, E.;Sánchez-Delgado, J. III Conferencia Española de Consenso sobre la infección por Helicobacter pylori. GASTROENTEROLOGIA Y HEPATOLOGIA. 2013. DOI: 10.1016/j.gastrohep.2013.01.011
  
  
• Carvajal-Carmona,L.;Zauber,A. G.;Jones,A. M.;Howarth,K.;Wang,J.;Cheng,T.;Riddell,R.;Lanas,A.;Morton,D.;Bertagnolli,M. M.;Tomlinson,I. Much of the genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas. GASTROENTEROLOGY. 2013. DOI: 10.1053/j.gastro.2012.09.016
  
  
• Picelli, S.; Lorenzo Bermejo, J.; Chang Claude, J.; Hoffmeister, M.; Fernández Rozadilla, C.; Carracedo, A.; Castells, A.; Castellví Bel, S.; Juan, D.M.; Raquel, M.; Marisa, M.; Francisco, C.; Jose, D.; Carolina, I.; Guadalupe, L.; Alberto, I.; Antoni, C.; Virgínia, P.; Sergi, C.B.; Balaguer, F.; Victoria, G.; Teresa, O.; María Dolores, G.; Maria, P.; Anna, S.; Leticia, M.; Miriam, C.; Josep, M.P.; Lanas, A.; Alcedo, J.; Ortego, F.J.; Joaquin, C.; Ma, S.D.; Mercedes, S.; Eloy, S.; Mariano, V.; Montserrat, A.; Anna, A.; Xavier, B.; Mar, I.; Agustín, S.; Felipe, B.; Gemma, N.; Beatriz, B.; de Josep, M.; Cristina, Á.; Marc, P.; Luis, B.; Ángel, C.; Inés, G.; Mikel, L.; Carlos, P.; María, D.M.R.; Elisabeth, H.; Jose, M.E.N.; Jose, L.E.; Artemio, P.; Rodrigo, J.; Cristina, A.; Laura, S.; Nuria, A.; Estefanía, R.; Lucía, P.C.; Joaquim, R.; Ángel, S.; Anna, G.; Joan, S.; Eduard, B.A.; Josefina, A.; Ramon, B.; Ana, M.G.; Fernando, C.; Antonio, B.; Eduardo, S.; Fernando, G.; Jaime, S.; Akiko, O.; Mercedes, L.; Enrique, M.; Jaime, C.; Pilar, C.; Miguel, M.; José, A.G.; Francisco, Q.; Elisa, O.; Juan, C.; Jaime, S.; Antoni, T.; Eugenia, S.; de Ma, L.C.; Antoni, T.; Juan, C.; Vicent, H.; Xavier, L.; Rosa, M.X.; Marta, P.; Mercè, R.; Anna, R.; Elisenda, P.; José, M.H.; Miquel, A.G.; Fernando, F.B.; Josep, M.V.; Antonio, S.; Jorge, E.; Montserrat, F.; Maria, E.; Josep, M.R.; Carmen, P.; Juan, B.; Joan, V.; Enrique, Q.; David, N.; Adolfo, P.; Antonio, M.; Lidia, A.; Vicente, P.; Virginia, P.; Teresa, S.; Dolors, G.; Eva, R.; Teresa, R.; Maria, P.; Ma, M.C.; Marta, M.; Lourdes, P.; Daniel, M.; Ángel, C.; Clara, R.P.; Ceres, F.R.; Ma, M.C.; Sabino, R.; Luis, R.; Javier, F.; Jose, L.C.; Luis, C.; Susana, O.; Federico, B.; Elena, P.; José, M.B.; Gloria, C.; Juan, J.S.; Antonio, N.; Naccarati, A.; Pardini, B.; Vodickova, L.; Müller, H.; Talseth Palmer, B.A.; Stibbard, G.; Peterlongo, P.; Nici, C.; Veneroni, S.; Li, L.; Casey, G.; Tenesa, A.; Farrington, S.M.; Tomlinson, I.; Moreno, V.; Van Wezel, T.; Wijnen, J.; Dunlop, M.; Radice, P.; Scott, R.J.; Vodicka, P.; Ruiz Ponte, C.; Brenner, H.; Buch, S.; Völzke, H.; Hampe, J.; Schafmayer, C.; Lindblom, A. Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility. PLOS ONE. 2013. DOI: 10.1371/journal.pone.0072091
  
  
• Gargallo,C. J.;Lanas,A. Is NSAIDs-related gastrointestinal damage preventable?. JOURNAL OF DIGESTIVE DISEASES. 2013. DOI: 10.1111/1751-2980.12019
  
  
• Lanas,A.;Polo-Tomás,M.;Casado-Arroyo,R. The aspirin cardiovascular/gastrointestinal risk calculator - A tool to aid clinicians in practice. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2013. DOI: 10.1111/apt.12240
  
  
• Lanas, A.; Polo-Tomas, M.; García-Rodríguez, L. A.; García, S.; Arroyo-Villarino, M.; Ponce, J.; Bujanda, L.; Calleja, J. L.; Calvet, X.; Feu, F.; Perez-Aisa, A.; Sung, J. J. Y. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: Comparison of event rates in routine clinical practice and a clinical trial. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2013. DOI: 10.3109/00365521.2012.758764
  
  
• Jover,R.;Zapater,P.;Polania,E.;Bujanda,L.;Lanas,A.;Hermo,J. A.;Cubiella,J.;Ono,A.;Gonzalez-Mendez,Y.;Peris,A.;Pellise,M.;Seoane,A.;Herreros-De-Tejada,A.;Ponce,M.;Marin-Gabriel,J. C.;Chaparro,M.;Cacho,G.;Fernandez-Diez,S.;Arenas,J.;Sopena,F.;De-Castro,L.;Vega-Villaamil,P.;Rodriguez-Soler,M.;Carballo,F.;Salas,D.;Morillas,J. D.;Andreu,M.;Quintero,E.;Castells,A. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies. GASTROINTESTINAL ENDOSCOPY. 2013. DOI: 10.1016/j.gie.2012.09.027
  
  
• Lanas,A.;Ponce,J.;Bignamini,A.;Mearin,F. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: A proof-of-concept study. DIGESTIVE AND LIVER DISEASE. 2013. DOI: 10.1016/j.dld.2012.09.006
  
  
• Rodríguez-Soler,M.;Pérez-Carbonell,L.;Guarinos,C.;Zapater,P.;Castillejo,A.;Barberá,V. M.;Juárez,M.;Bessa,X.;Xicola,R. M.;Clofent,J.;Bujanda,L.;Balaguer,F.;Reñé,J. -M;De-Castro,L.;Marín-Gabriel,J. C.;Lanas,A.;Cubiella,J.;Nicolás-Pérez,D.;Brea-Fernández,A.;Castellví-Bel,S.;Alenda,C.;Ruiz-Ponte,C.;Carracedo,A.;Castells,A.;Andreu,M.;Llor,X.;Soto,J. L.;Payá,A.;Jover,R. Risk of cancer in cases of suspected lynch syndrome without germline mutation. GASTROENTEROLOGY. 2013. DOI: 10.1053/j.gastro.2013.01.044
  
  
• Sostres, C.;Gargallo, C. J.;Lanas, A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. ARTHRITIS RESEARCH & THERAPY. 2013. DOI: 10.1186/ar4175
  
  
• Scheiman,J. M.;Herlitz,J.;Veldhuyzen,Van Zanten;Lanas,A.;Agewall,S.;Nauclér,E. C.;Svedberg,L. -E;Nagy,P. Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: The oberon trial. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2013. DOI: 10.1097/FJC.0b013e31827cb626
  
  
• Smolen,J. S.;Schoels,M. M.;Nishimoto,N.;Breedveld,F. C.;Burmester,G. R.;Dougados,M.;Emery,P.;Ferraccioli,G.;Gabay,C.;Gibofsky,A.;Gomez-Reino,J.;Jones,G.;Kvien,T. K.;Murakami,M.;Betteridge,N.;Bingham Iii,C. O.;Bykerk,V.;Choy,E. H.;Combe,B.;Cutolo,M.;Graninger,W.;Lanas,A.;Martin-Mola,E.;Montecucco,C.;Ostergaard,M.;Pavelka,K.;Rubbert-Roth,A.;Sattar,N.;Scholte-Voshaar,M.;Tanaka,Y.;Trauner,M.;Valentini,G.;Winthrop,K. L.;de Wit,M.;Van,Der Heijde. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. ANNALS OF THE RHEUMATIC DISEASES. 2013. DOI: 10.1136/annrheumdis-2012-202469
  
  
• Lanas, Ángel. Actualización en hemorragia gastrointestinal de origen no varicoso. GASTROENTEROLOGIA Y HEPATOLOGIA. 2013. DOI: 10.1016/S0210-5705(13)70054-2
  
  
• Soriano,L. C.; Bueno,H.; Lanas,A.; Rodrguez,L. A. G. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation. THROMBOSIS AND HAEMOSTASIS. 2013. DOI: 10.1160/TH13-04-0326
  
  
• Den Hollander, W. J.; Sostres, C.; Kuipers, E. J.; Lanas, A. Helicobacter pylori and Nonmalignant Diseases. HELICOBACTER. 2013. DOI: 10.1111/hel.12074
  
  
• Sostres,C.;Lacarta,P.;Lanas,A. Screening for adenocarcinoma in Barrett's esophagus: Yes or no, when and how?. GASTROENTEROLOGIA Y HEPATOLOGIA. 2013. DOI: 10.1016/j.gastrohep.2012.11.010
  
  
• Focks, J. J.;Brouwer, M. A.;Van Oijen, M. G. H.;Lanas, A.;Bhatt, D. L.;Verheugt, F. W. A. Concomitant use of clopidogrel and proton pump inhibitors: Impact on platelet function and clinical outcome- A systematic review. HEART. 2013. DOI: 10.1136/heartjnl-2012-302371
  
  
• Lanas, A.;Plazas, M. J.;Gimeno, E.;Muã’oz-Tudurãœ, M. Gastroprotection in NSAID and low-dose aspirin users: A cross-sectional study in primary care. GASTROENTEROLOGIA Y HEPATOLOGIA. 2012. DOI: 10.1016/j.gastrohep.2011.10.004
  
  
• Piazuelo, E.;Santander, S.;Cebriâ·n, C.;Jimãˆnez, P.;Pastor, C.;Garcãœa-Gonzâ·lez, M. A.;Esteva, F.;Esquivias, P.;Ortego, J.;Lanas, A. Characterization of the prostaglandin E 2 pathway in a rat model of esophageal adenocarcinoma. CURRENT CANCER DRUG TARGETS. 2012. DOI: 10.2174/156800912799095199
  
  
• Santander Ballestãœn, S.;Cebriâ·n, C.;Esquivias, P.;Conde, B.;Esteva, F.;Jimãˆnez, P.;Ortego, J.;Lanas, ¡.;Piazuelo, E. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice. INTERNATIONAL JOURNAL OF ONCOLOGY. 2012. DOI: 10.3892/ijo.2011.1219
  
  
• Arber,N.;Lieberman,D.;Wang,T. C.;Zhang,R.;Sands,G. H.;Bertagnolli,M. M.;Hawk,E. T.;Eagle,C.;Coindreau,J.;Zauber,A.;Lanas,A.;Levin,B. The APC and PreSAP trials: A post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo. CLINICAL THERAPEUTICS. 2012. DOI: 10.1016/j.clinthera.2012.02.001
  
  
• Lanas,A.;Goldstein,J. L.;Chan,F. K. L.;Wilcox,C. M.;Peura,D. A.;Li,C.;Sands,G. H.;Scheiman,J. M. Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR). ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2012. DOI: 10.1111/j.1365-2036.2012.05213.x
  
  
• Lanas,A.;Polo-Tomás,M.;Roncales,P.;Gonzalez,M. A.;Zapardiel,J. Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2012. DOI: 10.1038/ajg.2012.13
  
  
• Chueca,E.;Lanas,A.;Piazuelo,E. Role of gastrin-peptides in Barrett's and colorectal carcinogenesis. WORLD JOURNAL OF GASTROENTEROLOGY. 2012. DOI: 10.3748/wjg.v18.i45.6560
  
  
• Lanas,A. Aspirin: The balance between benefits and harms. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY. 2012. DOI: 10.1016/j.bpg.2012.03.006
  
  
• Esquivias,P. ;Morandeira,A.; Escartín,A.; Cebrián,C.; Santander,S.; Esteva,F.; García-González,M. A.; Ortego,J.; Lanas,A.; Piazuelo,E. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats. WORLD JOURNAL OF GASTROENTEROLOGY. 2012. DOI: 10.3748/wjg.v18.i35.4866
  
  
• García-González, M.A.; Nicolás-Pérez, D.; Lanas, A.; Bujanda, L.; Carrera, P.; Benito, R.; Strunk, M.; Sopeña, F.; Santolaria, S.; Piazuelo, E.; Jiménez, P.; Campo, R.; Espinel, J.; Manzano, M.; Geijo, F.; Pellisé, M.; González-Huix, F.; Espinós, J.; Zaballa, M.; Titó, L.; Barranco, L.; Pazo, R.; Quintero, E. Prognostic role of host cyclooxygenase and cytokine genotypes in a caucasian cohort of patients with gastric adenocarcinoma. PLOS ONE. 2012. DOI: 10.1371/journal.pone.0046179
  
  
• Lanas,A. Gastrointestinal bleeding associated with NSAIDs, antiplatelet therapy and anticoagulant agent. GASTROENTEROLOGIA Y HEPATOLOGIA. 2012. DOI: 10.1016/S0210-5705(12)70032-8
  
  
• Curtis, J. R.;Lanas, A.;John, A.;Johnson, D. A.;Schulman, K. L. Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis. ARTHRITIS CARE & RESEARCH. 2012. DOI: 10.1002/acr.21764
  
  
• Arroyo,R. C.;Polo-Tomas,M.;Roncalés,M. P.;Scheiman,J.;Lanas,Á. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: Long-term follow-up of a cohort of patients commonly using PPI co-therapy. HEART. 2012. DOI: 10.1136/heartjnl-2012-301632
  
  
• Sostres, C.;Lanas, A. Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?. DRUGS. 2011. DOI: 10.2165/11585320-000000000-00000
  
  
• Lanas, A.;Garcia-Tell, G.;Armada, B. ;Oteo-Alvaro, A. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC MEDICINE. 2011
  
  
• Burmester, G. R.;Lanas, A.;Biasucci, L.;Hermann, M.;Lohmander, S.;Olivieri, I.;Scarpignato, C.;Smolen, J.;Hawkey, C.;Bajkowski, A.;Berenbaum, F.;Breedveld, F.;Dieleman, P.;Dougados, M.;Macdonald, T.;Mola, E. M.;Mets, T.;Van, Den N. ;Stoevelaar, H. The appropriate use of non-steroidal antiinflammatory drugs in rheumatic disease: Opinions of a multidisciplinary European expert panel. ANNALS OF THE RHEUMATIC DISEASES. 2011. DOI: 10.1136/ard.2010.128660
  
  
• Lanas Arbeloa, Á. Advances in gastrointestinal diseases related to non-steroidal anti-inflammatory drugs and antiplatelet agents. GASTROENTEROLOGIA Y HEPATOLOGIA. 2011. DOI: 10.1016/S0210-5705(11)70005-X
  
  
• Lanas, A. Gastrointestinal bleeding associated with low-dose aspirin use: Relevance and management in clinical practice. EXPERT OPINION ON DRUG SAFETY. 2011. DOI: 10.1517/14740338.2010.507629
  
  
• Lanas, A.;Aabakken, L.;Fonseca, J.;Mungan, Z. A.;Papatheodoridis, G. V.;Piessevaux, H.;Cipolletta, L.;Nuevo, J. ;Tafalla, M. Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2011. DOI: 10.1111/j.1365-2036.2011.04651.x
  
  
• Lanas, A.; García-Rodríguez, L. A.; Polo-Tomás, M.; Ponce, M.; Quintero, E.; Perez-Aisa, M.; Gisbert, J. P.; Bujanda, L.; Castro, M.; Muñoz, M.; Del-Pino, M.; Garcia, S.; Calvet, X. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2011. DOI: 10.1111/j.1365-2036.2010.04563.x
  
  
• Casado-Arroyo,R.;Muñoz-Villalenguas,M.;Lanas Arbeloa,Á. Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?. GASTROENTEROLOGIA Y HEPATOLOGIA. 2011. DOI: 10.1016/j.gastrohep.2011.04.002
  
  
• Kawai, T.;Lanas, A.;Goto, S. European physicians don't like cytoprotective agents?. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. 2011. DOI: 10.3164/jcbn.10-140
  
  
• Appelman,H. D.;Umar,A.;Orlando,R. C.;Sontag,S. J.;Nandurkar,S.;El-Zimaity,H.;Lanas,A.;Parise,P.;Lambert,R.;Shields,H. M. Barrett's esophagus: Natural history. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2011. DOI: 10.1111/j.1749-6632.2011.06057.x
  
  
• Mccormack,P. L.;Lanas,A.;Mckenna,F.;Patrignani,P.;Simon,L. S. Celecoxib: A review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. DRUGS. 2011
  
  
• Abulí,A.;Fernández-Rozadilla,C.;Giráldez,M. D.;M Oz,J.;Gonzalo,V.;Bessa,X.;Bujanda,L.;R É,J. M.;Lanas,A.;García,A. M.;Saló,J.;Argüello,L.;Vilella,A.;Carr O,R.;Jover,R.;Xicola,R. M.;Llor,X.;Carvajal-Carmona,L.;Tomlinson,I. P. M.;Kerr,D. J.;Houlston,R. S.;Piqué,J. M.;Carracedo,A.;Castells,A.;Andreu,M.;Ruiz-Ponte,C.;Castellví-Bel,S. A two-phase case-control study for colorectal cancer genetic susceptibility: Candidate genes from chromosomal regions 9q22 and 3q22. BRITISH JOURNAL OF CANCER. 2011. DOI: 10.1038/bjc.2011.296
  
  
• Sopeña,F.;Lanas,A. Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2011. DOI: 10.1177/1756283X11412820
  
  
• Patrignani,P.;Tacconelli,S.;Bruno,A.;Sostres,C.;Lanas,A. Managing the adverse effects of nonsteroidal anti-inflammatory drugs. EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2011. DOI: 10.1586/ecp.11.36
  
  
• Goldstein,J. L.;Chan,F. K. L.;Lanas,A.;Wilcox,C. M.;Peura,D.;Sands,G. H.;Berger,M. F.;Nguyen,H.;Scheiman,J. M. Haemoglobin decreases in NSAID users over time: An analysis of two large outcome trials. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2011. DOI: 10.1111/j.1365-2036.2011.04790.x
  
  
• Lanas, A.; Mccarthy, D.; Voelker, M.; Brueckner, A.; Senn, S.; Baron, J.A. Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds - Gastrointestinal adverse effects: A meta-analysis of randomized clinical trials. DRUGS IN R&D. 2011. DOI: 10.2165/11593880-000000000-00000
  
  
• Lanas,A.;Wu,P.;Medin,J.;Mills,E. J. Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2011. DOI: 10.1016/j.cgh.2011.05.020
  
  
• Sostres,C.;Lanas,A. Epidemiology and Demographics of Upper Gastrointestinal Bleeding: Prevalence, Incidence, and Mortality. GASTROINTESTINAL ENDOSCOPY CLINICS OF NORTH AMERICA. 2011. DOI: 10.1016/j.giec.2011.07.004
  
  
• Ferrandez, A.;Navarro, M.;Diez, M.;Sopeña, F.;Roncales, P.;Polo-Tomas, M.;Sainz, R. ;Lanas, A. Risk factors for advanced lesions undetected at prior colonoscopy: Not always poor preparation. ENDOSCOPY. 2010
  
  
• Ladabaum, U.;Ferrandez, A. ;Lanas, A. Cost-effectiveness of colorectal cancer screening in high-risk spanish patients: Use of a validated model to inform public policy. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2010
  
  
• Lanas, A. Inhibidores de la bomba de protones y clopidogrel en el paciente cardiovascular: ¿riesgo cardiovascular versus riesgo gastrointestinal?. GASTROENTEROLOGIA Y HEPATOLOGIA. 2010
  
  
• Lanas, A. Editorial: Upper GI bleeding-associated mortality: Challenges to improving a resistant outcome. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2010
  
  
• Lanas, A.;Calvet, X.;Feu, F.;Ponce, J.;Gisbert, J. P. ;Barkun, A. First spanish consensus on peptic ulcer bleeding management. MEDICINA CLINICA. 2010
  
  
• Lanas, A.;Muñoz, M.;Caballero Correa, M. ;Martínez Jiménez, P. Análisis de las diferencias entre indicación y prescripción de gastroprotección en pacientes con factores de riesgo tratados con antiinflamatorios no esteroideos: estudio GAP. GASTROENTEROLOGIA Y HEPATOLOGIA. 2010
  
  
• Lanas, A.;Tornero, J. ;Zamorano, J. L. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: The LOGICA study. ANNALS OF THE RHEUMATIC DISEASES. 2010
  
  
• Lanas, Angel. A review of the gastrointestinal safety data-a gastroenterologist's perspective. RHEUMATOLOGY (OXFORD). 2010
  
  
• Lanas, Angel. Upper GI Bleeding-Associated Mortality: Challenges to Improving a Resistant Outcome. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2010
  
  
• Chan, F. K. L.;Cryer, B.;Goldstein, J. L.;Lanas, A.;Peura, D. A.;Scheiman, J. M.;Simon, L. S.;Singh, G.;Stillman, M. J.;Wilcox, C. M.;Berger, M. F.;Breazna, A. ;Dodge, W. A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract. JOURNAL OF RHEUMATOLOGY. 2010
  
  
• Chan, F. K. L.;Lanas, A.;Scheiman, J.;Berger, M. F.;Nguyen, H. ;Goldstein, J. L. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): A randomised trial. THE LANCET. 2010
  
  
• Abuli, A.;Bessa, X.;Gonzalez, J. R.;Ruiz Ponte, C.;Caceres, A.;Muñoz, J.;Gonzalo, V.;Balaguer, F.;Fernandez Rozadilla, C.;Gonzalez, D.;de Castro, L.;Clofent, J.;Bujanda, L.;Cubiella, J.;Rene, J. M.;Morillas, J. D.;Lanas, A.;Rigau, J.;Garcia, A. M.;Latorre, M.;Salo, J.;Fernandez Banares, F.;Arguello, L.;Peña, E.;Vilella, A.;. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype. GASTROENTEROLOGY. 2010
  
  
• Bhatt, D. L.;Cryer, B. L.;Contant, C. F.;Cohen, M.;Lanas, A.;Schnitzer, T. J.;Shook, T. L.;Lapuerta, P.;Goldsmith, M. A.;Laine, L.;Scirica, B. M.;Murphy, S. A. ;Cannon, C. P. Clopidogrel with or without omeprazole in coronary artery disease. NEW ENGLAND JOURNAL OF MEDICINE. 2010
  
  
• Borras, E.;Pineda, M.;Blanco, I.;Jewett, E. M.;Wang, F.;Teule, A.;Caldes, T.;Urioste, M.;Martinez-Bouzas, C.;Brunet, J.;Balmana, J.;Torres, A.;Ramon y Cajal, T.;Sanz, J.;Perez-Cabornero, L.;Castellvi-Bel, S.;Alonso, A.;Lanas, A.;Gonzalez, S.;Moreno, V.;Gruber, S. B.;Rosenberg, N. A.;Mukherjee, B.;Lazaro, C. ;Capella, G. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. CANCER RESEARCH. 2010
  
  
• Bujanda, L.;Sarasqueta, C.;Hijona, E.;Hijona, L.;Cosme, A.;Gil, I.;Elorza, J. L.;Asensio, J. I.;Larburu, S.;Enriquez-Navascues, J. M.;Jover, R.;Balaguer, F.;Llor, X.;Bessa, X.;Andreu, M.;Paya, A.;Castells, A.;Morillas, J. D.;Munoz, R.;Manzano, M.;Colina, F.;Diaz, J.;Ibarrola, C.;Lopez, G.;Ibanez, A.;Pinol, V.;Castellvi-Bel. Colorectal cancer prognosis twenty years later. WORLD JOURNAL OF GASTROENTEROLOGY. 2010
  
  
• Casado-Arroyo, R.;Scheiman, J. M.;Polo-Tomas, M.;Saini, S. D.;del Rio, A.;Guastello, E. ;Lanas, A. Underutilization of gastroprotection for at-risk patients undergoing percutaneous coronary intervention: Spain compared with the United States. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2010
  
  
• Sostres, C.;Gargallo, C. J.;Arroyo, M. T. ;Lanas, A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY. 2010
  
  
• Jimenez, P.;Piazuelo, E.;Cebrian, C.;Ortego, J.;Strunk, M.;Garcia-Gonzalez, M. A.;Santander, S.;Alcedo, J. ;Lanas, A. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2010
  
  
• García-González, Ma; Aísa, Ma; Strunk, M; Benito, R; Piazuelo, E; Jiménez, P; Sopeña, F; Lanas, A. Relevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal production. HUMAN IMMUNOLOGY. 2009. DOI: 10.1016/j.humimm.2009.07.024
  
  
• Richy, F.;Scarpignato,C.;Lanas,A.;Reginster,J. Efficacy and Safety of Piroxicam Revisited. A Global Meta-Analysis of Randomised Clinical Trials. PHARMACOLOGICAL RESEARCH. 2009
  
  
• Hart, J.;Hawkey,C. J.;Lanas,A.;Naesdal,J.;Talley,N. J.;Thomson,A. B. R.;Yeomans,N. D. Predictors of Gastroduodenal Erosions in Patients Taking Low-Dose Aspirin. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2009
  
  
• Hunt, R. H.;Lanas,A.;Stichtenoth,D. O.;Scarpignato,C. Myths and Facts in the use of Anti-Inflammatory Drugs. ANNALS OF MEDICINE. 2009
  
  
• Alcedo, J.;Ferrandez,A.;Arenas,J.;Sopeña,F.;Ortego,J.;Sainz,R.;Lanas,A. Trends in Barrett's Esophagus Diagnosis in Southern Europe: Implications for Surveillance. DISEASES OF THE ESOPHAGUS. 2009
  
  
• Lanas Arbeola, A. Should Helicobacter Pylori be Eradicated in Patients Who Will Receive Prolonged NSAID Treatment?. GASTROENTEROLOGIA Y HEPATOLOGIA. 2009
  
  
• Lanas, A.;Esplugues,J. V.;Zapardiel,J.;Sobreviela,E. Education-Based Approach to Addressing Non-Evidence-Based Practice in Preventing NSAID-Associated Gastrointestinal Complications. WORLD JOURNAL OF GASTROENTEROLOGY. 2009
  
  
• Lanas, A.;Ferrandez,A. NSAIDs and the Colon. CURRENT OPINION IN GASTROENTEROLOGY. 2009
  
  
• Garcia Gonzalez, M. A.;Quintero, E.;Benito, R.;Strunk, M.;Nicolas, D.;Parra-Blanco, A.;Santolaria, S.;Sopena, F.;Piazuelo, E.;Jimenez, P.;Badia, M.;Espinel, J.;Campo, R.;Manzano, M.;Geijo, F.;Pellise, M.;Gonzalez-Huix, F.;Nieto, M.;Espinos, J.;Tito, L.;Bujanda, L.;Zaballa, M.;Angeles Perez-Aisa, M.;Maria Mendez-Sanchez, I.;Lanas, A. Gastric Cancer Susceptibility: The Role of Gstm1, Gstt1, and Gstp1 Gene Polymorphisms. ANNALS OF ONCOLOGY. 2009
  
  
• Lanas, A.; Garcia-Rodriguez, L. A.; Polo-Tomas, M.; Ponce, M.; Alonso-Abreu, I.; Angeles Perez-Aisa, M.; Perez-Gisbert, J.;Bujanda, L.;Castro, M.;Muñoz, M.;Rodrigo, L.;Calvet, X.;Del-Pino, D.;Garcia, S. Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2009. DOI: 10.1038/ajg.2009.164
  
  
• Lanas, A.;Sopeña,F. Nonsteroidal Anti-Inflammatory Drugs and Lower Gastrointestinal Complications. GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 2009
  
  
• Lanas, A.;Tafalla,M.;Nuevo,J. Clinical Predictors of Bleeding Continuation Or Re-Bleeding After an Initial Episode of Non-Variceal Upper Gastrointestinal Bleeding: An Observational European Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2009
  
  
• Cremades, N.;Velazquez-Campoy, A.;Martinez-Julvez, M.;Neira, J. L.;Perez-Dorado, I.;Hermoso, J.;Jimenez, P.;Lanas, A.;Hoffman, P. S.;Sancho, J. Discovery of Specific Flavodoxin Inhibitors as Potential Therapeutic Agents Against Helicobacter Pylori Infection. ACS CHEMICAL BIOLOGY. 2009
  
  
• Moore, A.;Bjarnason,I.;Cryer,B.;Garcia-Rodriguez,L.;Goldkind,L.;Lanas,A.;Simon,L. Evidence for Endoscopic Ulcers as Meaningful Surrogate Endpoint for Clinically Significant Upper Gastrointestinal Harm. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2009
  
  
• Nardulli, G.;Lanas,A. Risk of Gastrointestinal Bleeding with Aspirin and Platelet Antiaggregants. GASTROENTEROLOGIA Y HEPATOLOGIA. 2009
  
  
• Smecuol, E.;Pinto Sanchez, M. I.;Suarez, A.;Argonz, J. E.;Sugai, E.;Vazquez, H.;Litwin, N.;Piazuelo, E.;Meddings, J. B.;Bai, J. C.;Lanas, A. Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study with a Multidimensional Assessment. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2009
  
  
• Ortego, J.;Esquivias, P.;Cebrian, C.;Santander, S.;Conde, B.;Emperador, S.;Sopena, F.;Garcia-Gonzalez, M.;Jimenez, P.;Lanas, A.;Piazuelo, E. Inhibition of Human Esophageal Adenocarcinoma Growth by both High and Low-Dose Aspirin in Nude Mice. VIRCHOWS ARCHIV. 2009
  
  
• Sostres, C.;Gargallo,C.;Lanas,A. Drug-Related Damage of the Ageing Gastrointestinal Tract. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY. 2009
  
  
• Esquivias, P.;Santander, S.;Cebrian, C.;Conde, B.;Emperador, S.;Sopena, F.;Garcia, A.;Jimenez, P.;Ortego, J.;Lanas, A.;Piazuelo, E. Both High and Low-Dose Aspirin Inhibits the Growth of Human Esophageal Adenocarcinoma in Nude Mice. ANNALS OF ONCOLOGY. 2009
  
  
• Piazuelo, E; Fuentes, J; García-González, Ma; Jiménez, P; Lanas, A. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin. CLINICAL THERAPEUTICS. 2008. DOI: 10.1016/j.clinthera.2008.01.020
  
  
• Lanas, A. Role of Nitric Oxide in the Gastrointestinal Tract. ARTHRITIS RESEARCH & THERAPY. 2008
  
  
• Yeomans, N.;Lanas, A.;Labenz, J.;Van Zanten, S. V.;Van Rensburg, C.;Racz, I.;Tchernev, K.;Karamanolis, D.;Roda, E.;Hawkey, C.;Naucler, E.;Svedberg, L. Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated with Continuous use of Low-Dose Aspirin. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2008
  
  
• Cebrian, C.;Ortego,J.;Piazuelo,E.;Jimenez,P.;Escartin,A.;Soteras,F.;Lanas,A. L-NAME Prevents the Development of Adenocarcinoma in a Rat Model of Barretts Esophagus. HISTOPATHOLOGY. 2008
  
  
• Baron, J. A.;Sandler, R. S.;Bresalier, R. S.;Lanas, A.;Morton, D. G.;Riddell, R.;Iverson, E. R.;Demets, D. L. Cardiovascular Events Associated with Rofecoxib: Final Analysis of the APPROVe Trial. THE LANCET. 2008
  
  
• Lanas, A. Improving on our Goal to Reduce NSAID-Induced GI Complications: A Challenging Task?. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2008
  
  
• Lanas, A; Ortego, J; Sopeña, F; Alcedo, J; Barrio, E; Bujanda, L; Cosme, A; Bajador, E; Parra-Blanco, A; Ferrandez, A; Piazuelo, E; Quintero, E; Pique, Jm. Effects of long-term cyclo-oxygenase 2 selective and acid inhibition on Barrett's oesophagus. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2007. DOI: 10.1111/j.1365-2036.2007.03429.x
  
  
• García-González, Ma; Lanas, A; Quintero, E; Nicolás, D; Parra-Blanco, A; Strunk, M; Benito, R; Angel Simón M; Santolaria S; Sopeña, F; Piazuelo, E; Jiménez, P; Pascual, C; Mas E; Irún P; Espinel, J; Campo, R; Manzano, M; Geijo, F ; Pellisé, M; González-Huix, F; Nieto M; Espinós, J; Titó, L; Bujanda L Zaballa, M. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: A nationwide multicenter study in Spain. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2007. DOI: 10.1111/j.1572-0241.2007.01423.x
  
  
• Lanas, A.;Baron, J. A.;Sandler, R. S.;Horgan, K.;Bolognese, J.;Oxenius, B.;Quan, H.;Watson, D.;Cook, T. J.;Schoen, R.;Burke, C.;Loftus, S.;Niv, Y.;Ridell, R.;Morton, D.;Bresalier, R. Peptic Ulcer and Bleeding Events Associated with Rofecoxib in a 3-Year Colorectal Adenoma Chemoprevention Trial. GASTROENTEROLOGY. 2007
  
  
• Richy, F.;Scarpignato,C.;Lanas,A.;Singh,G. Management of Osteoarticular Conditions: The Role of Piroxicam Revisited. OSTEOPOROSIS INTERNATIONAL. 2007
  
  
• Lanas, A.;Garcia-Rodriguez, L. A.;Arroyo, M. T.;Bujanda, L.;Gomollon, F.;Forne, M.;Aleman, S.;Nicolas, D.;Feu, F.;Gonzalez-Perez, A.;Borda, A.;Castro, M.;Poveda, M. J.;Arenas, J.;Aeg. Effect of Antisecretory Drugs and Nitrates on the Risk of Ulcer Bleeding Associated with Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, and Anticoagulants. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2007
  
  
• Lanas, A.;Scheiman,J. Low-Dose Aspirin and Upper Gastrointestinal Damage: Epidemiology, Prevention and Treatment. CURRENT MEDICAL RESEARCH AND OPINION. 2007
  
  
• Singh, G.;Scarpignato,C.;Richy,F.;Arana,A.;Lanas,A. Bias and Observational Studies: The Case of NSAID-INDUCED GI Complications. ANNALS OF THE RHEUMATIC DISEASES. 2007
  
  
• Lanas, A.;Ferrandez,A. Inappropriate Prevention of NSAID-Induced Gastrointestinal Events among Long-Term Users in the Elderly. DRUGS & AGING. 2007
  
  
• Heading,R.;Bardhan,K.;Hollerbach,S.;Lanas,A.;Fisher,G. Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome - a European perspective. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2006
  
  
• Yeomans,N.;Lanas,A.;Labenz,J.;Van Zanten,S. V.;Van Rensburg,C.;Racz,I. Prevention of low dose aspirin-associated gastroduodenal ulcers and upper gastrointestinal symptoms in patients receiving esomeprazole 20 mg per day. EUROPEAN HEART JOURNAL. 2006
  
  
• Arroyo,M.;Lanas,A. NSAIDs-induced gastrointestinal damage: Review. MINERVA GASTROENTEROLOGICA. 2006
  
  
• Lanas,A. Prevention and treatment of NSAID-induced gastroduodenal injury. CURRENT TREATMENT OPTIONS IN GASTROENTEROLOGY. 2006
  
  
• Lanas,A.;Ferrandez,A. NSAID-induced gastrointestinal damage: Current clinical management and recommendations for prevention. CHINESE JOURNAL OF DIGESTIVE DISEASES PRINT. 2006
  
  
• Lanas, A;Garcia-Rodriguez, L.A;Arroyo, M.T;Gomollon, F;Feu, F;Gonzalez-Perez, A;Zapata, E;Bastida, G;Rodrigo, L;Santolaria, S;Guell, M;de Argila, C.M;Quintero, E;Borda, F;Pique, J.M. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. GUT. 2006
  
  
• Lanas,Angel;Hunt,Richard. Prevention of anti-inflammatory drug-induced gastrointestinal damage: Benefits and risks of therapeutic strategies. ANNALS OF MEDICINE. 2006
  
  
• Lanas,Angel;Scarpignato,Carmelo. Microbial flora in NSAID-induced intestinal damage: A role for antibiotics?. DIGESTION. 2006
  
  
• Baron, J.A;Sandler, R.S;Bresalier, R.S;Quan, H;Riddell, R;Lanas, A;Bolognese, J.A;Oxenius, B;Horgan, K;Loftus, S;Morton, D.G. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. GASTROENTEROLOGY. 2006
  
  
• Mearin,F.;Garcia-Gonzalez,M. A.;Strunk,M.;Zarate,N.;Malagelada,J. R.;Lanas,A. Association between achalasia and nitric oxide synthase gene polymorphisms. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2006
  
  
• Piazuelo,E.; Jimenez,P.; Strunk,M.; Santander,S.; Garcia,A.; Esteva,F.; Lanas,A. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus. PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2006. DOI: 10.1016/j.prostaglandins.2006.09.002
  
  
• Ferrandez, A; Benito, R; Arenas, J; Garcia-Gonzalez, M.A; Sopena, F; Alcedo, J; Ortego, J; Sainz, R; Lanas, A. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC GASTROENTEROLOGY. 2006. DOI: 10.1186/1471-230X-6-7
  
  
• Garcia-Gonzalez, M.A; Strunk, M; Piazuelo, E; Benito, R; Santolaria, S; Jimenez, P; Sopena, F; Pascual, C; Simon, M.A; Sainz, R; Lanas, A. TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. GENES AND IMMUNITY. 2006. DOI: 10.1038/sj.gene.6364341
  
  
• Gracia,J. A.;Ramirez,J. M.;Aguilella,V.;Elia,M.;Lanas,A.;Diez,A. M. Cap polyposis: an unrecognized condition. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2006
  
  
• Wilcox, C.M;Allison, J;Benzuly, K;Borum, M;Cryer, B;Grosser, T;Hunt, R;Ladabaum, U;Lanas, A;Paulus, H;Regueiro, C;Sandler, R.S;Simon, L. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2006
  
  
• Bresalier, R.S;Sandler, R.S;Quan, H;Bolognese, J.A;Oxenius, B;Horgan, K;Lines, C;Riddell, R;Morton, D;Lanas, A;Konstam, M.A;Baron, J.A. Cardiovascular Events Associated With Rofecoxib in a Colorectal Adenoma Chemoprevention Trial. NEW ENGLAND JOURNAL OF MEDICINE. 2005
  
  
• Piazuelo, E.;Cebrian, C.;Escartin, A.;Jimenez, P.;Soteras, F.;Ortego, J.;Lanas, A. Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. WORLD JOURNAL OF GASTROENTEROLOGY. 2005
  
  
• Lanas, A. Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications. POSTGRADUATE MEDICINE. 2005
  
  
• Jimenez, P.; Piazuelo, E.; Sanchez, M. T.; Ortego, J.; Soteras, F.; Lanas, A. Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. WORLD JOURNAL OF GASTROENTEROLOGY. 2005. DOI: 10.3748/wjg.v11.i18.26
  
  
• Perez Aisa, M. A.;Pino, D. Del;Siles, M.;Lanas, A. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2005
  
  
• Garcia Gonzalez, M. A.;Lanas, A.;Wu, J.;Benito, R.;Santolaria, S.;Crusius, B.;Peña, S. Lack of association of IL-12 p40 gene polymorphism with peptic ulcer disease. HUMAN IMMUNOLOGY. 2005
  
  
• Yeomans, N.D;Lanas, A.I;Talley, N.J;Thomson, A.B.R;Daneshjoo, R;Eriksson, B;Appelman Eszczuk, S;Langstrom, G;Naesdal, J;Serrano, P;Singh, M;Skelly, M.M;Hawkey, C.J. Prevalence and Incidence of Gastroduodenal Ulcers During Treatment With Vascular Protective Doses of Aspirin. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2005
  
  
• Garcia Gonzalez, M.A;Savelkoul, P.H.M;Benito, R;Santolaria, S;Crusius, J.B.A;Pea, A.S;Lanas, A. No Allelic Variant Associations of the Il-1 and Tnf Gene Polymorphisms in the Susceptibility to Duodenal Ulcer Disease. INTERNATIONAL JOURNAL OF IMMUNOGENETICS. 2005
  
  
• Lanas, A. Potent Gastric Acid Inhibition in the Management of Barrett's Oesophagus. DRUGS. 2005
  
  
• Lanas, A;Perez Aisa, M.A;Feu, F;Ponce, J;Saperas, E;Santolaria, S;Rodrigo, L;Balanzo, J;Bajador, E;Almela, P;Navarro, J.M;Carballo, F;Castro, M;Quintero, E. A Nationwide Study of Mortality Associated With Hospital Admission Due to Severe Gastrointestinal Events and Those Associated With Nonsteroidal Antiinflammatory Drug Use. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2005
  
  
• Lanas, A. The Appropriate Use of Proton-Pump Inhibitor Co-Therapy With Nonsteroidal Anti-Inflammatory Drugs and Cyclo-Oxygenase-2 Selective Inhibitors. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2005
  
  
• Lanas, A. Benefits, Problems and Alternatives to Cox-2 Inhibition. CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2005
  
  
• Arroyo, T.;Forne, M.;Argila, C. M. De;Feu, F.;Arenas, J.;Vega, J. de La;Garrigues, V.;Mora, F.;Castro, M.;Bujanda, L.;Cosme, A.;Castiella, A.;Gisbert, J. P.;Hervas, A.;Lanas, A. The Prevalence of Peptic Ulcer Not Related to Helicobacter Pylori or Non-Steroidal Anti-Inflammatory Drug Use Is Negligible in Southern Europe. HELICOBACTER. 2004
  
  
• Lanas, A. Economic Analysis of Strategies in the Prevention of Non-Steroidal Anti-Inflammatory Drug-Induced Complications in the Gastrointestinal Tract. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2004
  
  
• Lanas, A. Prevencion y tratamiento de la gastroenteropatia por antiinflamatorios no esteroideos. REVISTA DE GASTROENTEROLOGÍA DE MÉXICO. 2004
  
  
• Lanas, A. Prevention of Aspirin-Induced Gastroduodenal Damage: H-Pylori Infection Eradication Versus Proton Pump Inhibitors or Both. DIGESTIVE AND LIVER DISEASE. 2004
  
  
• Kimmey, M. B.;Lanas, A. Review Article: Appropriate Use of Proton Pump Inhibitors With Traditional Nonsteroidal Anti-Inflammatory Drugs and Cox-2 Selective Inhibitors. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2004
  
  
• Piazuelo, E. ;Lanas, A. La defensa de la mucosa esofagica como diana terapeutica en la enfermedad por reflujo gastroesofagico. GASTROENTEROLOGIA Y HEPATOLOGIA. 2004
  
  
• Lanas, A.;Panes, J.;Pique, J. M. Clinical Implications of Cox-1 and/or Cox-2 Inhibition for the Distal Gastrointestinal Tract. CURRENT PHARMACEUTICAL DESIGN. 2003
  
  
• Lanas, A. Nuevas perspectivas terapéuticas en el esófago de Barrett. CARDIOVASCULAR RESEARCH. 2003
  
  
• Garcia-Gonzalez, M. A.;Lanas, A.;Savelkoul, P. H. M.;Santolaria, S.;Benito, R.;Crusius, J. B. A.;Peña, A. S. Association of Interleukin 1 Gene Family Polymorphisms With Duodenal Ulcer Disease. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003
  
  
• Lanas Arbeloa, A. COXIB vs AINE no específico + gastroprotector. La mejor opción es un COXIB. SEMINARIOS DE LA FUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA. 2003
  
  
• Lanas, A.;Rodrigo, L.;Marquez, J. L.;Bajador, E.;Perez Roldan, F.;Cabrol, J.;Quintero, E.;Montoro, M.;Gomollon, F.;Santolaria, S.;Lorente, S.;Cucala, M.;Nuevo, J. Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2003
  
  
• Perez Aisa, A. ;Sopeña, F. ;Arceiz, E. ;Ortego, J. ;Sainz, R. ;Lanas, A. Effect of exogenous administration of transforming growth factor-beta and famotidine on the healing of duodenal ulcer under the impact of indomethacin. DIGESTIVE AND LIVER DISEASE. 2003
  
  
• Lanas, A. ;Jimenez, P. ;Ferrandez, A. ;Escartin, A. ;Arenas, J. ;Esteva, F. ;Ortego, J. Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis. INFLAMMATION. 2003
  
  
• Lanas, A. Nuevas perspectivas terapeuticas en el esofago de Barrett. GASTROENTEROLOGIA Y HEPATOLOGIA. 2003
  
  
• Lanas, A. ;Serrano, P. ;Bajador, E. ;Fuentes, J. ;Sainz, R. Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2003
  
  
• Piazuelo, E.; Jimenez, P.; Lanas, A. Cox-2 Inhibition in Esophagitis, Barrett's Esophagus and Esophageal Cancer. CURRENT PHARMACEUTICAL DESIGN. 2003
  
  
• Lanas, A. Clinical experience with cyclooxygenase-2 inhibitors. RHEUMATOLOGY (OXFORD). 2002
  
  
• Serrano, P. ;Lanas, A. ;Arroyo, M. T;Ferreira, I. J. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2002
  
  
• Perez Aisa, A.;Sopena Biarge, F.;Arceiz Gonzalo, E.;Sainz Samitier, R.;Ortego Diez de Retana, J.;Lanas Arbeloa, A. Efecto de la administracion exogena de PDGF y EGF en la cicatrizacion de la ulcera duodenal en ratas tratadas con indometacina. GASTROENTEROLOGIA Y HEPATOLOGIA. 2002
  
  
• Lorente, S. ;Doiz, O. ;Serrano, M.T. ;Castillo, J. ;Lanas, A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells.. GUT. 2002. DOI: 10.1136/gut.50.1.13
  
  
• Lanas, Angel;Ferrandez, Angel. Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding. EXPERT OPINION ON DRUG SAFETY. 2002
  
  
• Serrano, Trinidad; Piazuelo, Elena; Benito, Rafael; Santolaria, Santos; Lanas, Angel. Bleeding duodenal ulcer and association with polymorphism of endothelial constitutive nitric oxide synthase gene.. DIGESTIVE DISEASES AND SCIENCES. 2002. DOI: 10.1023/A:1015021603681
  
  
• Lanas, Angel; Soteras, Fernando; Jimenez, Pilar; Fiteni, Isabel; Piazuelo, Elena; Royo, Yolanda; Ortego, Javier; Inarrea, Pedro; Esteva, Francisco. Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits. DIGESTIVE DISEASES AND SCIENCES. 2001
  
  
• Lanas, A. I. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. AMERICAN JOURNAL OF MEDICINE. 2001
  
  
• Lanas, A. ;Santolaria, S. Gastroesophageal reflux disease (GERD): current agents and future perspective. CURRENT PHARMACEUTICAL DESIGN. 2001
  
  
• Lanas, A. ;Pique, J. M;Ponce, J. Estrategia clinica para el paciente que precisa antiinflamatorios no esteroides: posicion de los inhibidores de la COX-2. GASTROENTEROLOGIA Y HEPATOLOGIA. 2001
  
  
• Lanas, A. ;Ferrandez, A. Should coronary patients taking a low-dose of aspirin receive gastroprotection?. REVISTA ESPANOLA DE CARDIOLOGIA. 2001
  
  
• Lanas, A. Efectos secundarios gastrointestinales por antiinflamatorios no esteroideos y costes en el sistema nacional de salud. ANALES DE MEDICINA INTERNA. 2001
  
  
• Lanas, A. Nonsteroidal anti-inflammatory drugs, low-dose aspirin, and potential ways of reducing the risk of complications. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2001
  
  
• Lanas, A. Cyclo-oxygenase-1/cyclo-oxygenase-2 non selective non-steroidal anti-inflammatory drugs: Epidemiology of gastrointestinal events. DIGESTIVE AND LIVER DISEASE. 2001
  
  
• Lanas, A. Aspirina y nitroglicerina: una buena asociacion para la mucosa gastrica. GASTROENTEROLOGIA Y HEPATOLOGIA. 2001
  
  
• Santolaria, S. ;Cabezali, R. ;Ortego, J. ;Castiella, T. ;Salinas, J. C;Lanas, A. Diaphragm disease of the small bowel: a case without apparent nonsteroidal antiinflammatory drug use. JOURNAL OF CLINICAL GASTROENTEROLOGY. 2001
  
  
• Garcia Gonzalez, M. A;Lanas, A. ;Santolaria, S. ;Crusius, J. B;Serrano, M. T;Peña, A. S. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2001. DOI: 10.1046/j.1365-2249.2001.01593.x
  
  
• Chan, Francis K. L.;Hawkey, Christopher J.;Lanas, Angel I. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate. AMERICAN JOURNAL OF MEDICINE. 2001
  
  
• Hawkey, Christopher J.;Lanas, Angel I. Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement. AMERICAN JOURNAL OF MEDICINE. 2001
  
  
• Santolaria, S; Lanas, A; Benito, R; Piazuelo, E; Sainz, R. Anticuerpos frente a las citotoxinas CagA y VacA y riesgo de úlcera péptica en pacientes con infección por Helicobacter pylori. MEDICINA CLINICA. 2001
  
  
• Lanas, A; García-González, Ma; Santolaria, S; Crusius, Jba; Serrano, Mt; Benito, R;, Peña, As;. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients.. GENES AND IMMUNITY. 2001
  
  
• Santolaria, S; Barrios, Y; Benito R; Piazuelo, E; Quintero, E; Lanas, A. Helicobacter pylori y factores inmunogenéticos del huésped: relevancia de los alelos HLADQA1 *0102 y *0301 en la úlcera péptica. GASTROENTEROLOGIA Y HEPATOLOGIA. 2001
  
  
• Santolaria, S {a};Lanas, A {a}. Reply: Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2000
  
  
• Soteras, F.;Lanas, A.;Fiteni, I.;Royo, Y.;Jimenez, P.;Inarrea, P.;Ortego, J.;Esteva, F. Nitric oxide and superoxide anion in low-grade esophagitis induced by acid and pepsin in rabbits. DIGESTIVE DISEASES AND SCIENCES. 2000
  
  
• Lanas, A. ;Arroyo, M. T. Dyspepsia and non-steroidal antiinflammatory agents: Not everything is an ulcer DISPEPSIA Y ANTIINFLAMATORIOS NO ESTEROIDES: NO TODO ES ULCERA. GASTROENTEROLOGIA Y HEPATOLOGIA. 2000
  
  
• Piazuelo, E.; Jimenez, P.; Lanas, A.; Garcia, A.; Esteva, F.; Sainz, R. Platelet-derived growth factor and epidermal growth factor play a major role in human colonic fibroblast repair activities. EUROPEAN SURGICAL RESEARCH. 2000
  
  
• Lanas, A. ;Arroyo, M. T. Farmacos antisecretores y profilaxis de los efectos secundarios gastrointestinales graves asociados al consumo de antiinflamatorios no esteroides. MEDICINA CLINICA. 2000
  
  
• Lanas, A.;Bajador, E.;Serrano, P.;Fuentes, J.;Carreño, S.;Guardia, J.;Sanz, M.;Montoro, M.;Sainz, R. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. NEW ENGLAND JOURNAL OF MEDICINE. 2000
  
  
• Lanas, A. ;Remacha, B. ;Sainz, R. ;Hirschowitz, B. I. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2000
  
  
• Lanas, A. Impacto economico de los efectos secundarios gastrointestinales asociados a antiinflamatorios no esteroides en el Servicio Nacional de Salud. MEDICINA CLINICA. 2000
  
  
• Lanas, A. Gastric cytoprotection: Current concepts. DRUGS OF TODAY. 2000
  
  
• Bajador, E.;Soria, M.T.;Piazuelo, E.;Yus, C.;Lanas, A. Helicobacter-Pylori Genotype, Host Dqa1 and Dqb1 Alleles in Chronic Active Gastritis with Intestinal Metaplasia. GASTROENTEROLOGY. 2000
  
  
• Arenas, J.;Ferrandez, A.;Lorente, S.;Sopena, F.;Aznar, C.;Sainz, R.;Lanas, A. Barretts-Esophagus - A 25-Year Epidemiologic-Study in a Stable-Population. GASTROENTEROLOGY. 2000
  
  
• Serrano, P.;Lanas, A.;Arroyo, M.T.;Casasnovas, J.A.;Ferreira, I. Risk Stratification of Upper Gastrointestinal-Bleeding in Cardiovascular Patients on Low-Dose Aspirin - A Cohort Study. GASTROENTEROLOGY. 2000
  
  
• Lanas, A.;Fuentes, J.;Benito, R.;Bajador, E.;Serrano, P.;Sainz, R. Helicobacter-Pylori Increases the Risk of Upper Gastrointestinal-Bleeding in Patients Taking Low-Dose Aspirin. GASTROENTEROLOGY. 2000
  
  
• Lanas, A.;Abad, J.M. Cost Stratification of Nonsteroidal Antiinflammatory Drug-Associated Gastrointestinal Side-Effects. GASTROENTEROLOGY. 2000
  
  
• Lanas, A.;Serrano, P.;Bajador, E.;Fuentes, J.;Guardia, J.;Sainz, R. Effect of Red Wine and Low-Dose Aspirin on the Risk of Upper Gastrointestinal-Bleeding - A Case-Control Study. GASTROENTEROLOGY. 2000
  
  
• Lanas, A.;Escartin, A.;Soteras, E.;Ortego, J.;Ferrandez, A.;Arenas, J.;Gimenez, P.;Sainz, R. Free-Radicals and Superoxide-Dismutase in the Progression of Reflux Esophagitis to Barretts-Esophagus in Rats. GASTROENTEROLOGY. 2000
  
  
• Soteras, F.;Algerich, A.;Sanchez, M.;Piazuelo, E.;Pilar, J.;Esteva, F.;Ferrandez, A.;Lanas, A. Superoxide Anion and Superoxide-Dismutase in Human Gastroesophageal Reflux Diseases. GASTROENTEROLOGY. 2000
  
  
• Arroyo, M. T;Lanas, A. ;Sainz, R. Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2000
  
  
• Lanas, Arbeloa Angel {a}. Infection by Helicobacter pylori and the administration of non steroid antiinflammatory drugs: Antibacterial treatment? Data against this. REVISTA ESPAÑOLA DE REUMATOLOGÍA. 2000
  
  
• Santolaria, S.;Lanas, A. Helicobacter-Pylori Infection Is a Protective Factor for Bleeding Gastric-Ulcers But Not for Bleeding Duodenal-Ulcers in NSAID Users - Reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2000
  
  
• Inarrea, P. ;Esteva, F. ;Cornudella, R. ;Lanas, A. Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2000
  
  
• Jimenez, P.; Lanas, A.; Piazuelo, E.; Esteva, F. Effects of extracellular pH on restitution and proliferation of rabbit oesophageal epithelial cells. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 1999
  
  
• Pinilla, I; Polo, V; Larrosa, Jm; Abecia, E; Pablo, Le; Lanas, A; Honrubia, Fm. Tissue effects of subconjunctival injection of different doses of mitomycin-C: Conjunctival and scleral toxicity. ANNALS OF OPHTHALMOLOGY. GLAUCOMA. 1999
  
  
• Lorente, S.;Lanas, A.;Aznar, C.;Jimenez, E.;Lozano, R. Hemorragia digestiva recidivante como complicacion de un diverticulo intraduodenal. GASTROENTEROLOGIA Y HEPATOLOGIA. 1999
  
  
• Santolaria, S.;Lanas, A.;Benito, R.;Perez-Aisa, M. A.;Montoro, M.;Sainz, R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 1999
  
  
• Pinilla, I.;Polo, V.;Larrosa, J. M.;Abecia, E.;Pablo, L. E.;Lanas, A.;Honrubia, F. M. Tissue effects of subconjunctival injection of different doses of mitomycin-C: Conjunctival and scleral toxicity. ANNALS OF OPHTHALMOLOGY (BIRMINGHAM). 1999
  
  
• Lanas, A.;Royo, Y.;Ortego, J.;Molina, M.;Sainz, R. Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. GASTROENTEROLOGY. 1999
  
  
• Lanas, A.;Hirschowitz, B. I. Toxicity of NSAIDs in the stomach and duodenum. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 1999
  
  
• Lanas, A. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding. ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 1999
  
  
• Piazuelo, E.; Lanas, A.; Jimenez, P.; Garcia-Gonzalez, A.; Esteva, F. In vitro wound repair by human gastric fibroblasts - Implications for ulcer healing. DIGESTIVE DISEASES AND SCIENCES. 1998
  
  
• Sopena, F.;Lanas, A.;Sainz, R. Esophageal motility and intraesophageal pH patterns in patients with esophagitis and chronic nonsteroidal anti-inflammatory drug use. JOURNAL OF CLINICAL GASTROENTEROLOGY. 1998
  
  
• Lanas, A.;Bajador, E.;Serrano, P.;Arroyo, M.;Fuentes, J.;Santolaria, S. Effects of nitrate and prophylactic aspirin on upper gastrointestinal bleeding: a retrospective case-control study. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. 1998
  
  
• Jimenez, P.; Lanas, A.; Piazuelo, E.; Esteva, F. Effect of growth factors and prostaglandin E-2 on restitution and proliferation of rabbit esophageal epithelial cells. DIGESTIVE DISEASES AND SCIENCES. 1998
  
  
• Lanas Arbeloa, A.;Serrano Aullo, M. T. Dano gastrico por AINE e inflamacion por Helicobacter pylori. Se potencian o se atenuan?. GASTROENTEROLOGIA Y HEPATOLOGIA. 1998
  
  
• Hawkey, C. J.;Tulassay, Z.;Szczepanski, L.;Van Rensburg, C. J.;Filipowicz-Sosnowska, A.;Lanas, A.;Wason, C. M.;Peacock, R. A.;Gillon, K. R. W. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. THE LANCET. 1998
  
  
• Lanas, A.; Garcia-Gonzalez, A.; Esteva, F.; Piazuelo, E.; Jimenez, P.; Morandeira, J. R. Collagen secretion by human gastric and skin fibroblasts: Implications for ulcer healing. EUROPEAN SURGICAL RESEARCH. 1998
  
  
• Lanas, A.;Sousa, F. L. Aspirin renders the oesophageal mucosa more permeable to acid and pepsin. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 1997
  
  
• Lanas Arbeloa, A. Barrera mucosa gastrica. Introduccion. GASTROENTEROLOGIA Y HEPATOLOGIA. 1997
  
  
• Naya, M. J.;Pereboom, D.;Ortego, J.;Alda, J. O.;Lanas, A. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. GUT. 1997
  
  
• Jimenez, P.;Lanas, A.;Piazuelo, E.;Bioque, G.;Esteva, F. Prostaglandin E-2 is the major arachidonic acid metabolite secreted by esophageal mucosal cells in rabbits. INFLAMMATION. 1997
  
  
• Arceiz, E.;Lanas, A.;Ortego, J.;Sainz, R. Platelet-derived growth factor reverses the effects induced by NSAIDs on ulcer healing. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 1997
  
  
• Serrano, M. T.;Lanas, A. I.;Lorente, S.;Sainz, R. Cytokine effects on pepsinogen secretion from human peptic cells. GUT. 1997
  
  
• Lanas, A. I.;Blas, J. M.;Ortego, J.;Soria, J.;Sainz, R. Adaptation of esophageal mucosa to acid- and pepsin-induced damage - Role of nitric oxide and epidermal growth factor. DIGESTIVE DISEASES AND SCIENCES. 1997
  
  
• Piazuelo Ortega, E.;Lanas Arbeloa, A. Los factores de crecimiento en la defensa de la barrera mucosa gastrica. GASTROENTEROLOGIA Y HEPATOLOGIA. 1997
  
  
• Lanas, A.;Serrano, P.;Bajador, E.;Esteva, F.;Benito, R.;Sainz, R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. GASTROENTEROLOGY. 1997
  
  
• Arroyo Villarino, M. T.;Lanas Arbeloa, A. Moco y secrecion de bicarbonato en la barrera mucosa gastrica. GASTROENTEROLOGIA Y HEPATOLOGIA. 1997
  
  
• Lanas, A.;Remacha, B. Risk factors in patients with refractory peptic ulcer. GASTROENTEROLOGY. 1996
  
  
• Artal, A.;Lanas, A.;Barrao, M. E.;Moliner, F. J.;Blas, J. M.;Lopez, J. Valoración de ranitidina y omeprazol intravenosos por pH-metría gástrica de 24 horas en hemorragia digestiva por úlcera duodenal. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1996
  
  
• Lanas, A. I.;Arroyo, M. T.;Esteva, F.;Cornudella, R.;Hirschowitz, B. I.;Sainz, R. Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. GUT. 1996
  
  
• Serrano Aullo, M. T.;Nerin de la Puerta, J.M.;Lanas Arbeloa, A. I. Efecto de la indometacina sobre la secrecion de pepsinogeno en celulas humanas aisladas in vitro. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1996
  
  
• Serrano Aullo, M. T.;Nerin de la Puerta, J. M.;Lanas Arbeloa, A. I. Effect of indomethacin on pepsinogen secretion in isolated human peptic cells. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1996
  
  
• Sainz, A.;Lanas, A.;Esteva, F.;Morandeira, J. R.;Sainz, R. Increased Gastric-Acid Secretion After Massive Small-Bowel Resection is Related to a Decrease in Enterogastrones. EUROPEAN SURGICAL RESEARCH. 1995
  
  
• Lanas, A. I. Antiinflamatorios no esteroides y patologia gastrointestinal. GASTROENTEROLOGIA Y HEPATOLOGIA. 1995
  
  
• Lanas, A. I.;Nerin, J.;Esteva, F.;Sainz, R. Nonsteroidal Antiinflammatory Drugs and Prostaglandin Effects on Pepsinogen Secretion by Dispersed Human Peptic Cells. GUT. 1995
  
  
• Tomey, B. R.;Arbeloa, A. L.;Samitier, R. S. Ulcera peptica refractaria: mecanismos patogenicos. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1995
  
  
• Lanas, A. I.;Remacha, B.;Esteva, F.;Sainz, R. Risk-Factors Associated with Refractory Peptic-Ulcers. GASTROENTEROLOGY. 1995
  
  
• Lanas, A. I.;Sousa, F. L.;Ortego, J.;Esteva, F.;Blas, J. M.;Soria, J.;Sainz, R. Aspirin renders the oesophageal mucosa more permeable to acid and pepsin. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 1995
  
  
• Lanas, A.;Artal, A.;Blas, J. M.;Arroyo, M. T.;Lopez Zaborras, J.;Sainz, R. Effect of Parenteral Omeprazole and Ranitidine on Gastric Ph and the Outcome of Bleeding Peptic-Ulcer. JOURNAL OF CLINICAL GASTROENTEROLOGY. 1995
  
  
• Serrano, M. T.;Arroyo, M. T.;Escalera, T.;Lanas, A. Diarrea, enteropatia proteinorreica y sarcoidosis. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1994
  
  
• Artal, A.; Freile, E.; Lanas, A. Favorable respuesta a la cisaprida en la pseudobstruccion aguda del colon (Sindrome de Ogilvie). REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1994
  
  
• Garcia, M. A.;Esteva, F.;Lanas, A.;Piazuelo, E.;Jimenez, P. Efectos de los antiinflamatoios y metabolitos del ácido araquidónico en la proliferación in vitro de fibroblastos. REVISTA DE EXPERIMENTACIÓN ANIMAL. 1993
  
  
• Nerin, J.;Lanas, A.;Serrano, M. T.;Esteva, F.;Sainz, R. Efectos de las prostaglandinas y de los antiinflamatorios no esteroideos sobre la secreción de pepsinógeno en células pepticas humanas aisladas in vitro. REVISTA DE EXPERIMENTACIÓN ANIMAL. 1993
  
  
• Lanas Arbeloa, A. I.;Hirschowitz, B. I. Antiinflamatorios no esteroideos y lesiones del tubo digestivo. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1993
  
  
• Soula, F. L.;Lanas, A.;Esteva, F.;Blas, J. M.;Ortego, J. La aspirina (aas) pero no el inhibidor de la lipooxigenasa facilita la agresión del ácido y la pepsina sobre la mucosa esofagica en conejos. REVISTA DE EXPERIMENTACIÓN ANIMAL. 1993
  
  
• Sopeña, F.;Lanas, A.;Esteva, F.;Arroyo, M. T.;Sainz, R. Inhibición de origen yeyunal de la secreción ácida gástrica. REVISTA DE EXPERIMENTACIÓN ANIMAL. 1993
  
  
• Montoro, M.;Gomollon, F.;Sopena, F.;Prats, E.;Banzo, J.;Gomollon, J. P.;Lopez Zaborras, J.;Lanas, A.;Sainz, R. Vaciamiento gastrico de solidos, secrecion acida y tabaco en la ulcera duodenal. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 1992
  
  
• Marquez, M.;Ducons, J. A.;Lanas, A.;Martinez, T.;Sainz, R. PREVALENCIA DE ULCERA PEPTICA EN FUMADORES Y NO FUMADORES EN ARAGON. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1989
  
  
• Lanas, A.;Sainz, R.;Morandeira, J. R.;Alcalde, J.;Abos, D.;Lozano, R. Role of Beta-Adrenoreceptors in the Inhibition of Gastric-Acid Secretion After Duodenal Acidification in Dogs. EUROPEAN SURGICAL RESEARCH. 1988
  
  
• Ducons, J. A.;Lanas, A.;Marquez, M.;Rubio, M.;Martinez, T.;Sainz, R. Aspectos epidemiológicos de la úlcera péptica en Aragón. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1987
  
  
• Lanas, A.;Alcalde, J.;Garcia Cabo, R.;Morandeira, J. R.;Sainz, R. Efecto de la vagotomía en los mecanismos duodenales que regulan la secreción gástrica. REVISTA ESPAÑOLA DE FISIOLOGÍA. 1987
  
  
• Lanas, A.;Alcalde, J.;Esteva, F.;Zaborras, J. L.;Morandeira, J. R.;Lozano, R.;Sainz, R. Efecto del estimulo beta-adrenergico sobre la secrecion gastrica: estudio experimental en perros. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1987
  
  
• Lanas, A.;Alcalde, J.;Martinez, T.;Gomollon, F.;Montoro, M.;Morandeira, J.;Abos, D.;Sainz, R. Efecto de la acidificación duodenal sobre la secreción gástrica y los niveles de secretina: estudio comparado en el hombre y en perros. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1986
  
  
• Lanas, A.;Ducons, J. A.;Marquez, M.;Martinez, T.;Sainz, R. PREVALENCIA DEL CONSUMO DE TABACO EN PACIENTES CON ULCERA PEPTICA EN ARAGON. GASTROENTEROLOGIA Y HEPATOLOGIA. 1986
  
  
• Lanas, A.;Alcalde, J.;Montoro, M.;Gomollon, F.;Morandeira, J.;Bueno, J.;Sainz, R. Papel de la gastrina en los mecanismos duodenales de inhibición de la secreción gástrica en perro y en humanos. REVISTA ESPAÑOLA DE FISIOLOGÍA. 1985
  
  
• Sainz, R.;Lanas Arbeloa, A.;Ortego, J.;Parra, P.;Bajador, E.;Gomollon, F.;Montoro, M. Hipersecrecion gastrica y ulcus duodenal: sospecha por el bioensayo de la existencia de un secretagogo no gastrinico. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1985
  
  
• Lanas, A.;Alcalde, J.;Montoro, M.;Martinez, T.;Lopez Zaborras, J.;Sainz, R. EFECTO DE LA ACIDIFICACION DUODENAL SOBRE LOS NIVELES SERICOS DE SECRETINA,INSULINA Y GLUCAGON: ESTUDIO COMPARADO EN PERROS Y EN HUMANOS. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1985
  
  
• Sainz Samitier, R.;Lanas Arbeloa, A. MECANISMOS DUODENALES INHIBIDORES DE LA SECRECION GASTRICA.I- ADMINISTRACION EXOGENA DE HORMONAS,GRASAS Y SUSTANCIAS HIPEROSMORALES. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1985
  
  
• Morandeira, J. R.;Sainz, R.;Lanas, A.;Parra, P.;Ortego, J.;Morandeira, A.;Remiro, P.;Salinas, J. C.;Lozano, R. Contribucion al aislamiento por bioensayo de nueva hormona acidosecretora gastrica. CIRUGÍA ESPAÑOLA. 1985
  
  
• Sainz, R.;Lanas, A.;Martinez, T.;Montoro, M.;Bueno, J. Physiopathological Heterogeneity of the Duodenal Mechanisms that Inhibit Gastric-Acid Secretion in Duodenal-Ulcer Patients. AMERICAN JOURNAL OF GASTROENTEROLOGY. 1985
  
  
• Sainz Samitier, R;Gomollon Garcia, F;Bajador Andreu, E;Lanas Arbeloa, A;Montoro Huguet, M;Morandeira Garcia, M J;Ortego Fernandez de Retana, J. Gastroenteritis eosinofilica:un caso de 35 años de evolucion. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1984
  
  
• Sainz Samitier, R.;Bajador Andreu, E. ;Lanas Arbeloa, A. ;Villalón Rico, C. ;Gimenez Martinez, A;Bueno Gomez, J. Estudios de predictibilidad en el cancer de pancreas mediante correlaciones multiples computarizadas. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1983
  
  
• Sainz Samitier, R. ;Lanas Arbeloa, A.;Moros Garcia, M. ;Bajador Andreu, E. ;Ortego Diaz de Retamar, J;Bueno Gomez, J. Alteraciones gastrointestinales en las distrofias musculares. A proposito de un caso de megacolon en la enfermedad de Duchenne. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1983
  
  
• Sainz Samitier, R.;Lanas Arbeloa, A.;Bajador Andreu, E.;Gimenez Martinez, A.;Rubio Nacher, M. HEMORRAGIA DIGESTIVA RECIDIVANTE. A PROPOSITO DE UN CASO DE LEIOMIOMA INTESTINAL. REVISTA ESPAÑOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO. 1980
  
  

Comunicaciones

• Caldas, M; Perez-Aisa, A; Castro, M; Bujanda, L; Lucendo, Aj; Fernandez, N; Hinojosa, J; Rodrigo, L; Pabon-Carrasco, M; Ferrer-Barcelo, L; Alonso-Galan, H; Perez-Lasala, J; Molina-Infante, J; Velayos, B; Barrio, J; Lanas, A; Dominguez-Cajal, M; Perona, M; Di Maira, T; Gomez-Rodriguez, Bj; Medina, E; Roldan, M; Mata-Romero, P; Modolell, I; Botargues, J; Jimenez-Moreno, M; Nyssen, Op; Marin, Ac; Donday, Mg; Garre, A; Megraud, F; Morain, Co; Mcnicholl, A; Gisbert, Jp. Efficacy of second-line regimens in SPain: Results from the EuroPean Registry on H. Pylori management (HP-EuReg). HELICOBACTER. 2019
  
  
• Sancho, J; Salillas, S; Alias, M; Michel, V; Mahia, A; Lucia, A; Rodrigues, L; Bueno, J; Galano-Frutos, Jj; de Reuse, H; Velazquez-Campoy, A; Carrodeguas, Ja; Sostres, C; Castillo, J; Ainsa, Ja; de Villegas, Mdd; Lanas, A; Touati, E. Efficacy of flavodoxin inhibitors against Helicobacter pylori drug-resistant clinical strains and in Hp-infected mice. HELICOBACTER. 2019
  
  
• Bollaerts, K.; Vora, P.; Sole, E.; Biccler, J.; Holl, K.; Langley, R.; Lanas, A.; Rodriguez, L.A.G.; Verstraeten, T.; Soriano-Gabarro, M. Population-level impact of low-dose aspirin on the prevention of cardiovascular disease, colorectal cancer and safety outcomes in Europe: A micro-simulation model. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019
  
  
• Herreros-Villanueva, M.; Duran-Sanchon, S.; Martin, A.; Perez-Palacios, R.; Vila-Navarro, E.; Marcuello, M.; Diaz-Centeno, M.; Cubiella, J.; Diez, M.; Bujanda, L.; Lanas, A.; Jover, R.; Hernandez, V.; Quintero, E.; Lozano, J.; Martinez, I.; Castells, A.; Gironella, M.; Arroyo, R. Plasma miRNAs signature validation for early detection of colorectal cancer. ANNALS OF ONCOLOGY. 2018. DOI: 10.1093/annonc/mdy149.017
  
  
• Llamazares, G.A.; Sostres, C.; Vigueras, A.E.; Lue, A.; Calavia, J.L.; Alcaine, C.; Guerrero, R.; Gonzales, A.G.; Ramirez, M.T.; Lacueva, A.; Gonzalez, S.; Lanas, A.; Ochoa, I.; Fernandez, L.J. Preserving tumor heterogeneity: A microfluidic reactor for ex vivo preservation of colorectal cancer biopsies. ANNALS OF ONCOLOGY. 2017. DOI: 10.1093/annonc/mdx361.038
  
  
• Bueno, J; Valledor, S; Muñoz, L; Arribas, J; Seral, C; Sostres, C; Ariño, I; Bellés, A; Lanas, A; Castillo, Fj. Comparación de cultivo e inmunocromatografía con PCR en tiempo real en la detección de Helicobacter pylori en pacientes refractarios al tratamiento y pacientes sin tratar. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2016
  
  
• Mccarthy, Denis;Lanas, Angel;Senn, Stephen;Baron, John;Brueckner, Andreas ;Voelker, Michael. Adverse Gastrointestinal Effects of Brief Use of Full Strength, OTC Aspirin in Randomized Clinical Trials: A Meta-Analysis. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2010
  
  
• Lanas, Angel I.; Garcia-Rodriguez, Luis A.; Ponce, Marta; Rodrigo, Luis; Bujanda, Luis; Gisbert, Javier P.; Alonso-Abreu, Inmaculada; Castro-Fernandez, Manuel; Perez-Aisa, Angeles; Polo-Tomás, Mónica; Calvet, Xavier; García, Santiago. 113 Clinical Impact and Time Trends of Upper and Lower Gastrointestinal Complications. GASTROENTEROLOGY. 2008. DOI: 10.1016/S0016-5085(08)60096-7
  
  
• Santander Ballestín, Sonia; Piazuelo, Elena; Conde Guerri, Blanca; Cebrián, C.; de la Igelesia, Fanny; Alcaine Gonzalez, Clara; Jimenez, Pilar; García, A.; Ortego, J.; Lanas, Ángel. Efecto de la inhibición de ciclooxigenasa en un modelo de xenoinjertos de adenocarcinoma esofáfico humano. GASTROENTEROLOGIA Y HEPATOLOGIA. 2006
  
  
• Lanas, A. Celecoxib Versus Diclofenac and Omeprazole to Prevent Recurrent Ulcer Bleeding. NEW ENGLAND JOURNAL OF MEDICINE. 2003
  
  
• Ng, F. H.;Wong, S. Y.;Chang, C. M.;Chen, W. H.;Kng, C.;Lanas, A. I.;Wong, B. C. Y. High Incidence of Clopidogrel-Associated Gastrointestinal Bleeding in Patients With Previous Peptic Ulcer Disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2003
  
  
• Lanas, A. Implications of Cox-2 Inhibition in the Gastrointestinal Tract - Preface. CURRENT PHARMACEUTICAL DESIGN. 2003
  
  
• Lorenta, S.;Lanas, A.;Castillo, J.;Doiz, O.;Serrano, M. T.;Piazuelo, E.;Soteras, F.;Sainz, R. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. GASTROENTEROLOGY. 1999
  
  
• Santolaria, S.;Lanas, A.;Benito, R.;Perez-Aisa, M. A.;Montoro, M.;Sainz, R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but is not for bleeding duodenal ulcers in NSAID users. GASTROENTEROLOGY. 1999
  
  
• Lanas, A.;Bajador, E.;Serrano, P.;Fuentes, J.;Carreno, S.;Guardia, J.;Sanz, M.;Montoro, M. Nitric oxide donors reduce the risk of upper gastrointestinal bleeding. A prospective case-control study. GASTROENTEROLOGY. 1999
  
  
• Piazuelo, E.;Lanas, A.;Argerich, A.;Jimenez, P.;Esteva, F.;Sainz, R. Influence of vitamin D receptor gene on Helicobacter pylori infection and peptic ulcer disease. GASTROENTEROLOGY. 1999
  
  
• Lanas, A.;Quintero, E.;Santolaria, S.;Barrios, Y.;Benito, R. Host HLA DQA gene is not associated with Helicobacter pylori infection and peptic ulcer diseases in a Causasian population. GASTROENTEROLOGY. 1999
  
  
• Lanas, A.;Molina, M.;Jimenez, P.;Ortego, J.;Esteva, F.;Soteras, F.;Sainz, R. Prostaglandins provide protection of the esophageal mucosa against acid and peptic-induced injury in rabbits. GASTROENTEROLOGY. 1998
  
  
• Esteva, E.;Inarrea, P.;Cornudella, R.;Lanas, A. Omeprazole does not interfere with the antiplatelet effect of low dose aspirin in man. GASTROENTEROLOGY. 1998
  
  
• Soteras, F.;Lanas, A.;Jimenez, P.;Esteva, F.;Sainz, R. Human epithelial esophageal cells have nitric oxide activity. GASTROENTEROLOGY. 1998
  
  
• Lanas, A.;Garcia, M. A.;Crusius, J. B. A.;Santolaria, S.;Serrano, M. T.;Peña, A. S. Helicobacter pylori and NSAID induced gastric and duodenal ulcers are associated with polymorphisms. GASTROENTEROLOGY. 1998
  
  
• Hawkey, C. J.;Tullassay, Z.;Szcepanski, L.;Van Rensburg, C. J.;Filipowicz-Sosnowska, A.;Lanas, A.;Peacock, R. A.;Gillon, K. R. W. Failure of Helicobacter pylori eradication to influence site-specific relapse in high risk NSAID users: Results of a large six month double blind randomised controlled clinical trial. GASTROENTEROLOGY. 1998
  
  
• Hawkey, C.;Tullassay, Z.;Szcepanski, L.;Van Rensburg, C. J.;Filipowicz-Sosnowska, A.;Lanas, A.;Wason, C. M.;Peacock, R. A.;Gillon, K. R. W. Failure of Helicobacter pylori eradication to influence site-specific relapse in high risk NSAID users. GUT. 1998
  
  
• Lorente, S; Doiz, O; Serrano, Mt; Castillo, J; Soteras, F; Lanas, A. Efecto del Helicobacter pylori sobre la secreción de pepsinógeno en células pépticas humanas aisladas in vitro. CARDIOVASCULAR RESEARCH. 1998
  
  
• Serrano, M. T.;Lanas, A.;Piazuelo, E.;Santolaria, S.;Benito, R.;Sainz, R. Bleeding duodenal ulcer patients are associated with a polymorphism of the endothelial constitutive nitric oxide synthase gene. GASTROENTEROLOGY. 1998
  
  
• Garciagonzalez, M. A.;Lanas, A.;Crusius, J. B. A.;Santolaria, S.;Garrote, J. A.;Serrano, T.;Peña, A. S. The polymorphic IL-1 beta. GASTROENTEROLOGY. 1997
  
  
• Lanas, A. Symposium: New approaches to management of NSAID toxicity resistant ulcers. GUT. 1997
  
  
• Jimenez, P.;Lanas, A.;Piazuelo, E.;Esteva, F.;Sainz, R. Small decreases in pH inhibit both proliferation and restitution of esophageal epithelial cells. GASTROENTEROLOGY. 1997
  
  
• Remacha, B.;Lanas, A. Long-term outcome of refractory peptic ulcer patients. GUT. 1997
  
  
• Arroyo, M.;Lanas, A.;Sainz, R. Prevention and healing of experimental NSAID-induced gastroduodenal lesions: Ebrotidine vs. omeprazole and ranitidine. GASTROENTEROLOGY. 1997
  
  
• Lanas, A.;Perez Aisa, M. A.;Arceiz, E.;Ortego, J.;Sopeña, F.;Sainz, R. PDGF and TGF-beta reverse the effects induced by indomethacin on duodenal ulcer healing. GASTROENTEROLOGY. 1997
  
  
• Soteras, F.;Lanas, A.;Royo, Y.;Salvador, E.;Esteva, F. Acid and pepsin induce nitric oxide synthase activity in the esophageal mucosa. GASTROENTEROLOGY. 1997
  
  
• Lanas, A.;Garcia, M. A.;Crusius, J. B. A.;Santolaria, S.;Serrano, M. T.;Peña, A. S. NSAID and Helicobacter pylori induced gastric ulcer bleeding is associated with a polymorphism of the TNF gene. GUT. 1997
  
  
• Piazuelo, E.;Lanas, A.;Jimenez, P.;Esteva, F.;Iñarrea, P.;Sainz, R. PDGF and bFGF stimulated gastrointestinal human fibroblast wound repair activities. GASTROENTEROLOGY. 1997
  
  
• Arroyo, M. T.;Lanas, A.;Sainz, R. Ebrotidine is superior to ranitidine in the prevention of indomethacin-induced gastric and duodenal lesions in rats. GASTROENTEROLOGY. 1996
  
  
• Lanas, A.;Fiteni, I.;Ortego, J.;Royo, Y.;Soteras, F.;Salvador, E.;Esteva, F.;Naya, M. J.;Alda, O. Nitric oxide and superoxide anion are involved in the mucosal protection and damage induced by acid and pepsin in chronic esophagitis. GASTROENTEROLOGY. 1996
  
  
• Jimenez, P.;Lanas, A.;Piazuelo, E.;Esteva, F. IGF-I and TGF-beta are the main growth factors affecting restitution and proliferation of esophageal mucosal cells. GASTROENTEROLOGY. 1996
  
  
• Sopena, F.;Lanas, A.;Nerin, J. M.;Sainz, R. Esophageal motility and intraesophageal pH patterns in patients with esophagitis and chronic NSAID use. GASTROENTEROLOGY. 1996
  
  
• Lanas, A.;Bajador, E.;Arroyo, M. T.;Fuentes, J.;Salvador, E.;Garcia, S.;Santolaria, S.;Sainz, R.;Uribarrena, R. Nitric oxide donors reduce the risk of upper gastrointestinal bleeding in patients treated with prophylactic aspirin. GASTROENTEROLOGY. 1996
  
  
• Lanas, A.;Arroyo, M. T.;Sainz, R. Low frequency of gastrointestinal complications in high risk patients receiving NSAIDs and omeprazole. GASTROENTEROLOGY. 1996
  
  
• Pinilla, I.;Larrosa, J. M.;Abecia, E.;Polo, V.;Ramirez, T.;Lanas, A.;Honrubia, F. M. Intraoperative Treatment with Mitomycin-C in Experimental Glaucoma Filtering Surgery - Dose-Effect on Conjunctival and Scleral Fibroblasts. VISION RESEARCH. 1995
  
  
• Lanas, A.;Remacha, B.;Esteva, F.;Sopena, F.;Sainz, R. Nsaid use is the Single most Important Exogenous Factor Associated with Refractory Peptic-Ulcers. GASTROENTEROLOGY. 1995
  
  
• Lanas, A.;Serrano, P.;Bajador, E.;Remacha, B.;Sainz, R. Objective Testing Reveals a Strong Association of Asa. GASTROENTEROLOGY. 1995
  
  
• Arceiz, E.;Lanas, A.;Ortego, J.;Sainz, R. Platelet-Derived Growth-Factor (Pdgf) Reverses the Effects Induced by Nsaids on Ulcer Healing. GASTROENTEROLOGY. 1995
  
  
• Naya, M. J.;Lanas, A.;Alda, O. Superoxide Anion Generation Plays and Important Role in Esophagitis Induced by Acid and Pepsin in Rabbits. GASTROENTEROLOGY. 1995
  
  
• Serrano, M. T.;Lanas, A.;Sainz, R. Cytokine Effects on Pepsinogen Secretion from Dispersed Human Peptic Cells. GASTROENTEROLOGY. 1995
  
  
• Lanas, A.;Piazuelo, E.;Soria, J.;Garcia, M. A.;Jimenez, P.;Esteva, F. In-Vitro Wound Repair by Human Gastric and Colonic Fibroblasts - Implications for Ulcer Healing. GASTROENTEROLOGY. 1995
  
  
• Lanas, A.;Blas, J. M.;Ortego, J.;Sousa, F. L.;Sainz, R. Adaptation of the Esophageal Mucosa to Acid and Pepsin - Role of Prostaglandins and Egf. GASTROENTEROLOGY. 1994
  
  
• Lanas, A.;Artal, A. A.;Blas, J. M.;Sopeña, F.;Lopez, J.;Sainz, R. Effects of Parenteral Omeprazole and Ranitidine on Gastric Ph and the Outcome of Bleeding Peptic-Ulcers. GASTROENTEROLOGY. 1994
  
  
• Lanas, A.;Sousa, F. L.;Ortego, J.;Esteva, F.;Blas, J. M.;Sainz, R. Esophageal Damage-Induced by Aspirin (Asa) is Ph Dependent and Reduced by Prostaglandin-E2. GASTROENTEROLOGY. 1994
  
  
• Lanas, A.;Gonzalez, M. A. G.;Piazuelo, E.;Jimenez, P.;Esteva, F. Collagen Production by Human Gastric Fibroblasts - Implications for Peptic-Ulcer Healing. GASTROENTEROLOGY. 1994
  
  
• Lanas, A.;Arroyo, M. T.;Esteva, F.;Cornudella, R.;Garcia, M. A.;Sainz, R. Aspirin (Asa)-Related Upper Gi Bleeders have an Exaggerated Bleeding-Time Response due to Asa use. GASTROENTEROLOGY. 1994
  
  
• Sopena, F.;Lanas, A.;Esteva, F.;Artal, A.;Sainz, R. Beta-Adrenoceptors and Cck are Involved in the Intestinal Mechanisms that Inhibit Gastric-Acid Secretion by Hyperosmotic Solutions in Dogs. GASTROENTEROLOGY. 1993
  
  
• Lanas, A.;Sousa, F. L.;Esteva, F.;Ortego, J.;Blas, J.;Sainz, R. Aspirin (Asa) Renders the Esophageal Mucosa More Permeable to Acid and Pepsin in Rabbits. GASTROENTEROLOGY. 1993
  
  
• Lanas, A.;Nerin, J.;Esteva, F.;Sainz, R. Nonsteroidal Antiinflammatory Drugs (Nsaids) Effects on Pepsinogen Secretion by Dispersed Human Peptic Cells. GASTROENTEROLOGY. 1993
  
  
• Sainz, R.;Lanas, A.;Martinez, T.;Montoro, M.;Sanz, M. Antral Inhibitory Mechanisms (Aim) of Gastric-Secretion (Gs) in Duodenal-Ulcer Patients (Dup) Evidence for Heterogeneity. DIGESTIVE DISEASES AND SCIENCES. 1986
  
  

Dirección de tesis

• Susceptibilidad genética del cáncer colorrectal. Influencia de polimorfismos genéticos en el desarrollo del cáncer colorrectal y lesiones preneoplásicas en familiares de primer grado de pacientes con cáncer colorrectal. Universidad de Zaragoza. Sobresaliente "Cum Laude". 10/02/16
  
  
• Estudio experimental para evaluar el papel del ácido acetil salicílico y otros AINEs en la prevención y tratamiento del adenocarcinoma de esófago. Universidad de Zaragoza. Sobresaliente "Cum Laude". 28/01/16
  
  
• Agentes antiplaquetarios y reisgo hemorrágico en la enfermedad coronaria. Universidad de Zaragoza. Sobresaliente "Cum Laude". 26/06/14
  
  
• Estudio de la COX-2 y la PGE2 en el desarrollo carcinogénico de esófago de Barrett humano a adencarcinoma de esófago. Universidad de Zaragoza. Sobresaliente "Cum Laude". 05/02/09
  
  
• Efecto de la inhibición selectiva de la ciclooxigenasa-2 en la prevención del esófago de Barrett y adenocarcinoma de esófago. Universidad de Zaragoza. Sobresaliente "Cum Laude". 09/12/08
  
  
• Estudio del papel de los receptores de prostaglandinas en la progresión de esofagitis por reflujo a esófago de Barret y adenocarcinoma invasivo. Universidad de Zaragoza. Sobresaliente "Cum Laude". 25/06/08
  
  
• Incidencia, prevalencia y evolución del esófago de Barrett en una población definida. Universidad de Zaragoza. Sobresaliente "Cum Laude". 26/09/05
  
  
• Papel de los radicales libres y el óxido nítrico en el adenocarcinoma inducido en un modelo de esófago de Barrett en rata y efecto de la quimioprevención. Universidad de Zaragoza. Sobresaliente "Cum Laude". 09/07/04
  
  
• Estudio de factores patogénicos ambientales y genéticos en la hemorragia digestiva alta por lesiones pépticas asociada a la ingesta crónica de AAS. Universidad de Zaragoza. Sobresaliente "Cum Laude". 16/09/03
  
  
• Papel de los radicales libres y enzimas antioxidantes en la enfermedad por reflujo gastroesofágico. Universidad de Zaragoza. Sobresaliente "Cum Laude". 29/11/01
  
  
• Estratificación del riesgo de hemorragia digestiva en el paciente cardiópata. Universidad de Zaragoza. Sobresaliente "Cum Laude". 09/12/99
  
  
• EFECTO DEL HELICOBACTER PYLORI SOBRE LA SECRECION DE PEPSINOGENO EN CELULAS PEPTICAS HUMANAS. Universidad de Zaragoza. Sobresaliente "Cum Laude". 01/07/99
  
  
• PAPEL DEL OXIDO NITRICO Y DEL ANION SUPEROXIDO EN LA ESOFAGITIS CRONICA EXPERIMENTAL EN CONEJOS PRODUCIDA CON ACIDO Y PEPSINA. Universidad de Zaragoza. Sobresaliente "Cum Laude". 28/06/99
  
  
• Estudio experimental de la administración exógena de factores decrecimiento en la reparación ulcerosa bajo el impacto de indometacina. Universidad de Zaragoza. Sobresaliente "Cum Laude". 01/07/98
  
  
• Relevancia de los polimorfismos de los genes de la interleuquina-1 receptor antagonista, factor de necrosis tumoral y HLA.DQA1 en la Etiopatogenia de la úlcera peptica. Universidad de Zaragoza. Apto cum laude. 18/12/97
  
  
• Papel de las prostaglandinas en un modelo experimental de esofagitis crónica inducida por ácido y pepsina. Universidad de Zaragoza. Apto cum laude. 05/12/97
  
  
• Esofagitis crónica en conejos: Un nuevo modelo experimental para el estudio de las enfermedades esofágicas relacionadas con la agresión ácido-péptica. Universidad de Zaragoza. Apto cum laude. 18/12/96
  
  
• EFECTO DEL FACTOR DE CRECIMIENTO PLAQUETARIO SOBRE LA CURACION DE LAS ULCERAS GASTRO-DUODENALES EXPERIMENTALES EN RATAS TRATADAS EN AINES. Universidad de Zaragoza. Apto cum laude. 25/09/95
  
  
• ESTUDIO DE LOS MECANISMOS DE SANGRADO EN LA HEMORRAGIA DIGESTIVA ASOCIADA A LA ASPIRINA: IDENTIFICACION DE PACIENTES SUSCEPTIBLES. Universidad de Zaragoza. Apto cum laude. 19/01/95
  
  
• ADAPTACION DE LA MUCOSA DEL ESOFAGO A LA AGRESION POR ACIDO Y PEPSINA. PAPEL DE LAS POTOSTAGLANDINAS, OXIDO NITRICO Y FACTOR DE CRECIMIENTO EPITELIAL. Universidad de Zaragoza. Apto cum laude. 13/01/95
  
  
• ULCERA PEPTICA REFRACTARIA: MECANISMOS PATOGENICOS. Universidad de Zaragoza. Apto cum laude. 23/03/94
  
  
• EFECTOS DE LOS ANTIINFLAMATORIOS NO ESTEROIDEOS SOBRE LA SECRECION DE PEPSINOGENO EN CELULAS PEPTICAS HUMANAS AISLADAS IN VITRO. Universidad de Zaragoza. Apto cum laude. 30/11/93
  
  
• MECANISMOS DE LESION DE LOS ANTIINFLAMATORIOS NO ESTEROIDEOS SOBRE LA MUCOSA ESOFAGICA: ESTUDIO EXPERIMENTAL. Universidad de Zaragoza. Apto cum laude. 11/11/93
  
  
• ESTUDIO EXPERIMENTAL SOBRE LOS MECANISMOS DE INHIBICION DE LA SECRECION ACIDA GASTRICA DE OIRIGEN INTESTINAL. Universidad de Zaragoza. Apto cum laude. 20/09/93
  
  

UNIZAR teaching of the last six courses

• Gastroenterología y hepatología. Graduado en Medicina. From the 2019-20 course to the 2024-25 course
  
  
• Trabajo fin de grado. Graduado en Medicina. During academic year 2023-24
  
  
• Investigación en especialidades médicas. Máster Universitario en Iniciación a la investigación en medicina. From the 2019-20 course to the 2023-24 course
  
  
• La microbiota y su relación con la inmunoterapia del cáncer. Máster Universitario en Inmunología Tumoral e Inmunoterapia del Cáncer. During academic year 2022-23
  
  
• Prácticas tuteladas. Graduado en Medicina. During academic year 2021-22
  
  
• Prácticas tuteladas. Graduado en Medicina. During academic year 2021-22
  
  
• Prácticas tuteladas. Graduado en Medicina. During academic year 2021-22
  
  
• Prácticas tuteladas. Graduado en Medicina. During academic year 2019-20
  
  
• Prácticas tuteladas. Graduado en Medicina. During academic year 2019-20